No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 1romA, 1.0000, 0.00, 1.000, 399, 399, CRYSTAL STRUCTURE OF NITRIC REDUCTASE FROM DENITRIFYING FUNGUS FUSARIUM OXYSPORUM
2, 2romA, 0.9989, 0.24, 1.000, 399, 399, CRYSTAL STRUCTURE OF NITRIC REDUCTASE FROM DENITRIFYING FUNGUS FUSARIUM OXYSPORUM COMPLEX WITH CARBON MONOXIDE
3, 1geiA, 0.9976, 0.36, 1.000, 399, 399, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
4, 5y5kB, 0.9971, 0.39, 1.000, 399, 399, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR : 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE ABSENCE OF NADH (NO-BOUND STATE) LIGHT DATA
5, 5y5lB, 0.9970, 0.39, 1.000, 399, 399, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE ABSENCE OF NADH (RESTING STATE)
6, 5y5jB, 0.9970, 0.40, 1.000, 399, 399, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE PRESENCE OF NADH (RESTING STATE)
7, 5y5iB, 0.9970, 0.40, 1.000, 399, 399, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE PRESENCE OF NADH (NO-BOUND STATE) LIGHT DATA
8, 5y5mB, 0.9969, 0.40, 1.000, 399, 399, SFX STRUCTURE OF CYTOCHROME P450NOR: A COMPLETE DARK DATA WITHOUT PUMP LASER (RESTING STATE) 
9, 1gejA, 0.9969, 0.41, 1.000, 399, 399, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
10, 1jfcA, 0.9968, 0.41, 1.000, 399, 399, X-RAY STRUCTURE OF NITRIC OXIDE REDUCTASE (CYTOCHROME P450NOR) IN THE FERROUS CO STATE AT ATOMIC RESOLUTION
11, 1f25A, 0.9966, 0.42, 0.997, 399, 399, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243ASN MUTANTS OF CYTOCHROME P450NOR
12, 5y5lA, 0.9965, 0.43, 1.000, 399, 399, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE ABSENCE OF NADH (RESTING STATE)
13, 5y5kA, 0.9965, 0.43, 1.000, 399, 399, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR : 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE ABSENCE OF NADH (NO-BOUND STATE) LIGHT DATA
14, 5y5mA, 0.9964, 0.44, 1.000, 399, 399, SFX STRUCTURE OF CYTOCHROME P450NOR: A COMPLETE DARK DATA WITHOUT PUMP LASER (RESTING STATE) 
15, 5y5jA, 0.9964, 0.44, 1.000, 399, 399, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE PRESENCE OF NADH (RESTING STATE)
16, 5y5iA, 0.9964, 0.44, 1.000, 399, 399, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE PRESENCE OF NADH (NO-BOUND STATE) LIGHT DATA
17, 1eheA, 0.9964, 0.44, 1.000, 399, 399, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
18, 1jfbA, 0.9963, 0.44, 1.000, 399, 399, X-RAY STRUCTURE OF NITRIC OXIDE REDUCTASE (CYTOCHROME P450NOR) IN THE FERRIC RESTING STATE AT ATOMIC RESOLUTION
19, 1cl6A, 0.9963, 0.44, 1.000, 399, 399, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND ITS SER286 MUTANTS AT CRYOGENIC TEMPERATURE
20, 1f24A, 0.9962, 0.45, 0.997, 399, 399, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243ALA MUTANTS OF CYTOCHROME P450NOR
21, 1f26A, 0.9961, 0.45, 0.997, 399, 399, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243VAL MUTANTS OF CYTOCHROME P450NOR
22, 1cmnA, 0.9960, 0.46, 0.997, 399, 399, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND THEIR SER286 MUTANTS AT CRYOGENIC TEMPERATURE
23, 5y5hA, 0.9959, 0.46, 1.000, 400, 399, SF-ROX STRUCTURE OF CYTOCHROME P450NOR (NO-BOUND STATE) DETERMINED AT SACLA
24, 1cmjA, 0.9959, 0.47, 0.997, 399, 399, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND THEIR SER286 MUTANTS AT CRYOGENIC TEMPERATURE
25, 5y5gA, 0.9957, 0.48, 1.000, 400, 399, STRUCTURE OF CYTOCHROME P450NOR IN NO-BOUND STATE: DAMAGED BY LOW-DOSE (0.72 MGY) X-RAY
26, 1ehfA, 0.9957, 0.48, 0.997, 399, 399, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
27, 1ehgA, 0.9954, 0.49, 0.997, 399, 399, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
28, 1ulwA, 0.9948, 0.52, 0.995, 399, 399, CRYSTAL STRUCTURE OF P450NOR SER73GLY/SER75GLY MUTANT
29, 1gedA, 0.9947, 0.53, 1.000, 399, 399, A POSITIVE CHARGE ROUTE FOR THE ACCESS OF NADH TO HEME FORMED IN THE DISTAL HEME POCKET OF CYTOCHROME P450NOR
30, 5y5fA, 0.9935, 0.46, 1.000, 399, 398, STRUCTURE OF CYTOCHROME P450NOR IN NO-BOUND STATE: DAMAGED BY LOW-DOSE (0.72 MGY) X-RAY
31, 1xqdA, 0.9662, 1.52, 0.992, 399, 399, CRYSTAL STRUCTURE OF P450NOR COMPLEXED WITH 3- PYRIDINEALDEHYDE ADENINE DINUCLEOTIDE
32, 5y1iB, 0.9465, 1.36, 0.370, 394, 389, THE CRYSTAL STRUCTURE OF GFSF
33, 2z36A, 0.9393, 1.73, 0.365, 403, 394, CRYSTAL STRUCTURE OF CYTOCHROME P450 MOXA FROM NONOMURAEA RECTICATENA (CYP105)
34, 2z36B, 0.9371, 1.78, 0.365, 404, 394, CRYSTAL STRUCTURE OF CYTOCHROME P450 MOXA FROM NONOMURAEA RECTICATENA (CYP105)
35, 5y1iA, 0.9345, 1.43, 0.369, 388, 385, THE CRYSTAL STRUCTURE OF GFSF
36, 3tywC, 0.9257, 1.93, 0.331, 398, 393, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
37, 3tywD, 0.9253, 1.94, 0.331, 399, 393, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
38, 3tywA, 0.9225, 2.00, 0.331, 397, 393, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
39, 3tywB, 0.9223, 2.01, 0.331, 397, 393, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
40, 5x7eA, 0.9217, 2.12, 0.369, 404, 393, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT) IN COMPLEX WITH 125-DIHYDROXYVITAMIN D2
41, 2zbzA, 0.9215, 2.10, 0.369, 404, 393, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT) IN COMPLEX WITH 125-DIHYDROXYVITAMIN D3
42, 3cv8A, 0.9211, 2.11, 0.369, 402, 393, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84F MUTANT)
43, 2zbyA, 0.9203, 2.11, 0.369, 400, 393, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT)
44, 3cv9A, 0.9170, 2.19, 0.366, 401, 393, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R73A/R84A MUTANT) IN COMPLEX WITH 1ALPHA25- DIHYDROXYVITAMIN D3
45, 3e5lA, 0.9127, 2.21, 0.343, 394, 391, CRYSTAL STRUCTURE OF CYP105P1 H72A MUTANT
46, 4ubsA, 0.9119, 2.18, 0.365, 393, 392, THE CRYSTAL STRUCTURE OF CYTOCHROME P450 105D7 FROM STREPTOMYCES AVERMITILIS IN COMPLEX WITH DICLOFENAC
47, 2zbxA, 0.9088, 2.16, 0.373, 399, 389, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (WILD TYPE) WITH IMIDAZOLE BOUND
48, 4xe3B, 0.9073, 2.17, 0.321, 394, 389, OLEP THE CYTOCHROME P450 EPOXIDASE FROM STREPTOMYCES ANTIBIOTICUS INVOLVED IN OLEANDOMYCIN BIOSYNTHESIS: FUNCTIONAL ANALYSIS AND CRYSTALLOGRAPHIC STRUCTURE IN COMPLEX WITH CLOTRIMAZOLE.
49, 2dkkA, 0.9043, 2.17, 0.257, 399, 389, STRUCTURE/FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
50, 2nz5A, 0.9036, 2.18, 0.257, 399, 389, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
51, 2nzaA, 0.9031, 2.19, 0.257, 397, 389, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
52, 3zsnC, 0.9023, 2.29, 0.308, 393, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
53, 3zsnB, 0.9021, 2.30, 0.308, 393, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
54, 3zsnA, 0.9020, 2.30, 0.308, 393, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
55, 3tzoB, 0.9020, 2.21, 0.272, 402, 389, THE ROLE OF I87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
56, 5de9B, 0.9017, 2.21, 0.272, 402, 389, THE ROLE OF ILE87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
57, 2y46C, 0.9017, 2.30, 0.308, 393, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
58, 2nz5B, 0.9016, 2.22, 0.257, 399, 389, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
59, 2y46B, 0.9015, 2.31, 0.308, 393, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
60, 4xe3A, 0.9014, 2.27, 0.319, 394, 389, OLEP THE CYTOCHROME P450 EPOXIDASE FROM STREPTOMYCES ANTIBIOTICUS INVOLVED IN OLEANDOMYCIN BIOSYNTHESIS: FUNCTIONAL ANALYSIS AND CRYSTALLOGRAPHIC STRUCTURE IN COMPLEX WITH CLOTRIMAZOLE.
61, 2y46A, 0.9014, 2.31, 0.308, 393, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
62, 2y5zC, 0.9013, 2.30, 0.308, 394, 389, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
63, 2y5zB, 0.9013, 2.30, 0.308, 394, 389, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
64, 2y5nA, 0.9013, 2.33, 0.308, 394, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN V IN P21 SPACE GROUP
65, 2y5zA, 0.9012, 2.30, 0.308, 393, 389, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
66, 4fxbA, 0.8999, 2.27, 0.328, 390, 390, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR: A CYTOCHROME P450 OXIDASE IN THE COELIBACTIN SIDEROPHORE BIOSYNTHETIC PATHWAY
67, 2ygxD, 0.8999, 2.29, 0.307, 393, 388, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
68, 2ygxB, 0.8997, 2.30, 0.307, 393, 388, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
69, 2y98A, 0.8996, 2.34, 0.306, 393, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN P21212 SPACE GROUP
70, 4mm0A, 0.8995, 2.25, 0.302, 392, 388, CRYSTAL STRUCTURE ANALYSIS OF THE PUTATIVE THIOETHER SYNTHASE SGVP INVOLVED IN THE TAILORING STEP OF GRISEOVIRIDIN
71, 4aw3B, 0.8993, 2.36, 0.308, 393, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286V MUTANT IN COMPLEX WITH MYCINAMICIN V IN P1 SPACE GROUP
72, 5mnvH, 0.8986, 2.39, 0.315, 395, 390, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
73, 5foiA, 0.8983, 2.27, 0.296, 389, 385, CRYSTAL STRUCTURE OF MYCINAMICIN VIII C21 METHYL HYDROXYLASE MYCCI FROM MICROMONOSPORA GRISEORUBIDA BOUND TO MYCINAMICIN VIII
74, 2ygxA, 0.8983, 2.31, 0.307, 393, 388, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
75, 2y5nB, 0.8983, 2.36, 0.308, 400, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN V IN P21 SPACE GROUP
76, 5foiB, 0.8980, 2.28, 0.296, 388, 385, CRYSTAL STRUCTURE OF MYCINAMICIN VIII C21 METHYL HYDROXYLASE MYCCI FROM MICROMONOSPORA GRISEORUBIDA BOUND TO MYCINAMICIN VIII
77, 2ygxC, 0.8980, 2.32, 0.307, 393, 388, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
78, 4oqsA, 0.8979, 1.83, 0.349, 384, 378, CRYSTAL STRUCTURE OF CYP105AS1
79, 2ycaA, 0.8979, 2.33, 0.307, 393, 388, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN P21212 SPACE GROUP
80, 4mm0B, 0.8976, 2.26, 0.302, 394, 388, CRYSTAL STRUCTURE ANALYSIS OF THE PUTATIVE THIOETHER SYNTHASE SGVP INVOLVED IN THE TAILORING STEP OF GRISEOVIRIDIN
81, 5de9A, 0.8975, 2.29, 0.272, 402, 389, THE ROLE OF ILE87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
82, 5mnvF, 0.8973, 2.42, 0.315, 395, 390, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
83, 4aw3A, 0.8970, 2.38, 0.308, 393, 389, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286V MUTANT IN COMPLEX WITH MYCINAMICIN V IN P1 SPACE GROUP
84, 3tzoA, 0.8967, 2.30, 0.275, 402, 389, THE ROLE OF I87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
85, 5it1C, 0.8963, 2.44, 0.357, 395, 387, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
86, 5it1B, 0.8961, 2.44, 0.357, 395, 387, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
87, 5it1D, 0.8959, 2.44, 0.357, 395, 387, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
88, 5it1A, 0.8958, 2.44, 0.357, 395, 387, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
89, 4wq0A, 0.8949, 2.51, 0.307, 397, 388, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP107W1 FROM STREPTOMYCES AVERMITILIS IN COMPLEX WITH OLIGOMYCIN A
90, 1se6B, 0.8939, 2.40, 0.272, 402, 390, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
91, 5mnvD, 0.8923, 2.50, 0.315, 394, 390, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
92, 3abaA, 0.8922, 2.68, 0.343, 397, 391, CRYSTAL STRUCTURE OF CYP105P1 IN COMPLEX WITH FILIPIN I
93, 4z5pB, 0.8920, 2.33, 0.306, 388, 385, CRYSTAL STRUCTURE OF THE LNMA CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.9 A RESOLUTION
94, 5mnvE, 0.8916, 2.27, 0.324, 390, 386, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
95, 4z5pA, 0.8910, 2.35, 0.306, 388, 385, CRYSTAL STRUCTURE OF THE LNMA CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.9 A RESOLUTION
96, 5mnvA, 0.8909, 2.52, 0.313, 397, 390, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
97, 3e5kA, 0.8889, 2.19, 0.342, 382, 380, CRYSTAL STRUCTURE OF CYP105P1 WILD-TYPE 4-PHENYLIMIDAZOLE COMPLEX
98, 2d0eA, 0.8882, 2.61, 0.274, 404, 390, SUBSTRATE ASSITED IN OXYGEN ACTIVATION IN CYTOCHROME P450 158A2
99, 5mnsE, 0.8861, 2.49, 0.319, 395, 385, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
100, 4wpzA, 0.8861, 2.33, 0.304, 386, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP107W1 FROM STREPTOMYCES AVERMITILIS
101, 2d09A, 0.8860, 2.63, 0.274, 404, 390, A ROLE FOR ACTIVE SITE WATER MOLECULES AND HYDROXYL GROUPS OF SUBSTRATE FOR OXYGEN ACTIVATION IN CYTOCHROME P450 158A2
102, 1gwiA, 0.8857, 2.70, 0.258, 402, 391, THE 1.92 A STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP154C1: A NEW MONOOXYGENASE THAT FUNCTIONALIZES MACROLIDE RING SYSTEMS
103, 6bldA, 0.8850, 2.45, 0.281, 414, 385, MYCOBACTERIUM MARINUM CYTOCHROME P450 CYP268A2 IN COMPLEX WITH PSEUDOIONONE
104, 3wvsA, 0.8843, 2.55, 0.302, 393, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450REVI
105, 5mnsA, 0.8840, 2.64, 0.320, 395, 388, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
106, 5mnsB, 0.8839, 2.64, 0.320, 395, 388, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
107, 2nzaB, 0.8837, 2.19, 0.260, 388, 381, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
108, 5mnvB, 0.8834, 2.64, 0.320, 394, 388, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
109, 2wm4A, 0.8831, 2.60, 0.266, 426, 387, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP124 IN COMPLEX WITH PHYTANIC ACID
110, 1t93A, 0.8827, 2.69, 0.274, 403, 390, EVIDENCE FOR MULTIPLE SUBSTRATE RECOGNITION AND MOLECULAR MECHANISM OF C-C REACTION BY CYTOCHROME P450 CYP158A2 FROM STREPTOMYCES COELICOLOR A3(2)
111, 5mnsC, 0.8826, 2.67, 0.320, 395, 388, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
112, 3e5jA, 0.8821, 2.76, 0.339, 390, 386, CRYSTAL STRUCTURE OF CYP105P1 WILD-TYPE LIGAND-FREE FORM
113, 5mnvC, 0.8818, 2.67, 0.320, 396, 388, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
114, 2x5wA, 0.8817, 2.55, 0.260, 409, 385, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH SUBSTRATE CHOLEST-4-EN-3-ONE
115, 1gwiB, 0.8817, 2.77, 0.258, 400, 391, THE 1.92 A STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP154C1: A NEW MONOOXYGENASE THAT FUNCTIONALIZES MACROLIDE RING SYSTEMS
116, 5mnsD, 0.8812, 2.69, 0.320, 395, 388, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
117, 3abbA, 0.8811, 2.07, 0.379, 383, 377, CRYSTAL STRUCTURE OF CYP105D6
118, 1s1fA, 0.8802, 2.67, 0.273, 397, 388, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
119, 4l0fA, 0.8783, 2.63, 0.249, 437, 385, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS (OPEN ACTIVE SITE)
120, 5l1uA, 0.8780, 2.78, 0.288, 397, 389, X-RAY STRUCTURE OF M81A MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
121, 4fxbB, 0.8780, 1.80, 0.330, 370, 370, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR: A CYTOCHROME P450 OXIDASE IN THE COELIBACTIN SIDEROPHORE BIOSYNTHETIC PATHWAY
122, 5l1pA, 0.8779, 2.79, 0.288, 397, 389, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE
123, 5l1sA, 0.8778, 2.79, 0.288, 397, 389, X-RAY STRUCTURE OF F232L MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
124, 5l1vA, 0.8777, 2.86, 0.292, 397, 390, X-RAY STRUCTURE OF M81C MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
125, 5l1qA, 0.8777, 2.86, 0.290, 397, 390, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH DIHYDROPENTALENOLACTONE F
126, 5l1oA, 0.8777, 2.79, 0.288, 397, 389, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
127, 5l1tA, 0.8772, 2.80, 0.288, 397, 389, X-RAY STRUCTURE OF M77S MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
128, 5l1rA, 0.8771, 2.87, 0.292, 397, 390, X-RAY STRUCTURE OF THE SUBSTRATE-FREE CYTOCHROME P450 PNTM
129, 4oqrA, 0.8763, 2.46, 0.347, 386, 380, STRUCTURE OF A CYP105AS1 MUTANT IN COMPLEX WITH COMPACTIN
130, 5l1wA, 0.8762, 2.91, 0.287, 396, 390, X-RAY STRUCTURE OF 2-MERCAPTOETHANOL MODIFIED M81C MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
131, 2bvjB, 0.8761, 2.48, 0.290, 391, 383, LIGAND-FREE STRUCTURE OF CYTOCHROME P450 PIKC (CYP107L1)
132, 3o1aA, 0.8756, 2.37, 0.257, 383, 377, STRUCTURE OF OXYE (CYP165D3) A CYTOCHROME P450 INVOLVED IN TEICOPLANIN BIOSYNTHESIS
133, 5mnsF, 0.8749, 2.71, 0.319, 393, 386, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
134, 6gk6A, 0.8742, 2.85, 0.281, 403, 388, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYTOCHROME P450 CYP267B1 IN COMPLEX WITH MYRISTIC ACID 
135, 5uhuA, 0.8742, 2.71, 0.312, 393, 388, SOLUTION CONFORMATION OF CYTOCHROME P450 MYCG WITH MYCINAMICIN IV BOUND
136, 2z3uA, 0.8742, 2.86, 0.268, 411, 388, CRYSTAL STRUCTURE OF CHROMOPYRROLIC ACID BOUND CYTOCHROME P450 STAP (CYP245A1)
137, 6gk5A, 0.8741, 2.86, 0.281, 403, 388, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP267B1 FROM SORANGIUM CELLULOSUM SO CE56 
138, 1cptA, 0.8729, 2.79, 0.264, 412, 387, CRYSTAL STRUCTURE AND REFINEMENT OF CYTOCHROME P450-TERP AT 2.3 ANGSTROMS RESOLUTION
139, 3a1lA, 0.8721, 2.93, 0.265, 411, 388, CRYSTAL STRUCTURE OF 1111 -DICHLOROCHROMOPYRROLIC ACID BOUND CYTOCHROME P450 STAP (CYP245A1)
140, 4apyA, 0.8712, 2.68, 0.278, 414, 385, ETHYLENE GLYCOL-BOUND FORM OF P450 CYP125A3 FROM MYCOBACTERIUM SMEGMATIS
141, 3iw0A, 0.8711, 2.69, 0.262, 407, 385, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 C2221 CRYSTAL FORM
142, 4j6cB, 0.8710, 3.06, 0.244, 406, 394, THE 1.9 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PROGESTERONE
143, 4jbtB, 0.8709, 3.06, 0.244, 407, 394, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH ANDROSTENEDIONE
144, 4j6cA, 0.8709, 3.06, 0.244, 407, 394, THE 1.9 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PROGESTERONE
145, 5dqnA, 0.8708, 2.61, 0.279, 410, 384, POLYETHYLENE 600-BOUND FORM OF P450 CYP125A3 MUTANT FROM MYOBACTERIUM SMEGMATIS - W83Y
146, 4jbtA, 0.8707, 3.06, 0.244, 407, 394, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH ANDROSTENEDIONE
147, 4j6bB, 0.8704, 3.01, 0.244, 405, 393, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PREGNENOLONE
148, 4j6bA, 0.8696, 2.96, 0.245, 405, 392, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PREGNENOLONE
149, 4j6dB, 0.8694, 3.03, 0.244, 406, 393, THE 2.4 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH TESTOSTERONE
150, 4j6dA, 0.8694, 3.03, 0.244, 406, 393, THE 2.4 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH TESTOSTERONE
151, 5gnmC, 0.8687, 2.71, 0.325, 401, 381, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
152, 3a4hA, 0.8685, 2.72, 0.323, 400, 381, STRUCTURE OF CYTOCHROME P450 VDH FROM PSEUDONOCARDIA AUTOTROPHICA (ORTHORHOMBIC CRYSTAL FORM)
153, 5gnmD, 0.8682, 2.76, 0.325, 401, 382, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
154, 2x5lA, 0.8680, 2.73, 0.262, 414, 385, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 ALTERNATIVE CRYSTAL FORM
155, 5mnvG, 0.8678, 2.27, 0.322, 380, 376, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
156, 3p3xA, 0.8674, 2.74, 0.257, 397, 381, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERM- AURH-I) FROM STREPTOMYCES THIOLUTEUS
157, 2wm5A, 0.8674, 2.82, 0.273, 425, 385, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP124
158, 2wi9B, 0.8669, 2.87, 0.288, 394, 389, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
159, 3p3xB, 0.8665, 2.75, 0.257, 399, 381, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERM- AURH-I) FROM STREPTOMYCES THIOLUTEUS
160, 5gnmB, 0.8655, 2.74, 0.325, 399, 381, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
161, 3oo3A, 0.8652, 2.07, 0.263, 371, 369, CRYSTAL STRUCTURE OF THE ORF6* (CYP165D3) MONOOXYGENASE INVOLVED IN TEICOPLANIN BIOSYNTHESIS
162, 5gnmA, 0.8645, 2.69, 0.326, 399, 380, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
163, 1eupA, 0.8645, 2.90, 0.301, 403, 385, X-RAY CRYSTAL STRUCTURE OF CYTOCHROME P450ERYF WITH ANDROSTENDIONE BOUND
164, 4umzB, 0.8643, 2.92, 0.290, 395, 389, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED SUBSTRATE MIMIC BEARING A 2-DIMETHYLAMINOMETHYLBENZOATE GROUP
165, 4jx1B, 0.8643, 2.46, 0.222, 405, 378, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
166, 4pxhA, 0.8642, 2.77, 0.253, 417, 383, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
167, 4bf4P, 0.8637, 2.96, 0.288, 396, 389, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
168, 3p3lA, 0.8637, 2.76, 0.266, 403, 380, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (WILDTYPE) FROM STREPTOMYCES THIOLUTEUS
169, 4umzA, 0.8635, 2.93, 0.290, 396, 389, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED SUBSTRATE MIMIC BEARING A 2-DIMETHYLAMINOMETHYLBENZOATE GROUP
170, 4jwuA, 0.8635, 2.47, 0.228, 405, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
171, 1oxaA, 0.8629, 2.96, 0.301, 403, 386, CYTOCHROME P450 (DONOR:O2 OXIDOREDUCTASE)
172, 1odoA, 0.8626, 3.02, 0.272, 395, 386, 1.85 A STRUCTURE OF CYP154A1 FROM STREPTOMYCES COELICOLOR A3(2)
173, 1egyA, 0.8626, 2.96, 0.301, 403, 386, CYTOCHROME P450ERYF WITH 9-AMINOPHENANTHRENE BOUND
174, 4pxhE, 0.8622, 2.79, 0.253, 407, 383, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
175, 4jx1A, 0.8621, 2.49, 0.225, 405, 378, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
176, 3p3lB, 0.8621, 2.79, 0.266, 403, 380, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (WILDTYPE) FROM STREPTOMYCES THIOLUTEUS
177, 4bf4O, 0.8620, 2.96, 0.290, 397, 389, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
178, 3p3zA, 0.8620, 2.69, 0.262, 407, 378, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH FROM STREPTOMYCES THIOLUTEUS IN COMPLEX WITH ANCYMIDOL
179, 2uuqA, 0.8620, 2.85, 0.245, 394, 384, CRYSTAL STRUCTURE OF CYP130 FROM MYCOBACTERIUM TUBERCULOSIS IN THE LIGAND-FREE FORM
180, 3w9cA, 0.8619, 2.33, 0.225, 401, 374, CRYSTAL STRUCTURE OF THE ELECTRON TRANSFER COMPLEX OF CYTOCHROME P450CAM WITH PUTIDAREDOXIN
181, 2vzmB, 0.8619, 2.94, 0.288, 394, 389, CRYSTAL STRUCTURE OF THE NARBOMYCIN-BOUND PIKC D50N MUTANT
182, 2wi9A, 0.8617, 2.96, 0.288, 396, 389, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
183, 2vz7B, 0.8615, 2.96, 0.288, 393, 389, CRYSTAL STRUCTURE OF THE YC-17-BOUND PIKC D50N MUTANT
184, 1k2oA, 0.8615, 2.50, 0.222, 406, 378, CYTOCHROME P450CAM WITH BOUND BIS(22 -BIPYRIDINE)-(5-METHYL-2-2 - BIPYRIDINE)-C2-ADAMANTANE RUTHENIUM (II)
185, 5gxgA, 0.8614, 2.33, 0.225, 401, 374, HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE ELECTRON TRANSFER COMPLEX OF CYTOCHROME P450CAM WITH PUTIDAREDOXIN
186, 3mgxB, 0.8613, 2.71, 0.237, 391, 380, CRYSTAL STRUCTURE OF P450 OXYD THAT IS INVOLVED IN THE BIOSYNTHESIS OF VANCOMYCIN-TYPE ANTIBIOTICS
187, 2xn8A, 0.8613, 2.69, 0.259, 409, 382, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125
188, 1jioA, 0.8613, 3.00, 0.301, 403, 386, P450ERYF/6DEB
189, 1qmqA, 0.8611, 2.50, 0.225, 406, 378, OPTICAL DETECTION OF CYTOCHROME P450 BY SENSITIZER-LINKED SUBSTRATES
190, 4yzrA, 0.8609, 2.83, 0.292, 388, 383, BACILLUS SUBTILIS 168 BACILLAENE POLYKETIDE SYNTHASE (PKS) CYTOCHROME P450 PKSS
191, 6giiA, 0.8608, 2.94, 0.203, 416, 384, THE CRYSTAL STRUCTURE OF TEPIDIPHILUS THERMOPHILUS P450 HEME DOMAIN 
192, 5nwsA, 0.8608, 3.05, 0.273, 395, 385, CRYSTAL STRUCTURE OF SAACMM INVOLVED IN ACTINOMYCIN BIOSYNTHESIS
193, 1k2oB, 0.8608, 2.60, 0.222, 406, 379, CYTOCHROME P450CAM WITH BOUND BIS(22 -BIPYRIDINE)-(5-METHYL-2-2 - BIPYRIDINE)-C2-ADAMANTANE RUTHENIUM (II)
194, 2whfA, 0.8605, 2.88, 0.245, 394, 384, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
195, 1se6A, 0.8605, 2.23, 0.275, 384, 371, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
196, 2wgyA, 0.8604, 2.82, 0.248, 394, 383, CRYSTAL STRUCTURE OF THE G243A MUTANT OF CYP130 FROM M. TUBERCULOSIS
197, 2vz7A, 0.8604, 2.96, 0.288, 396, 389, CRYSTAL STRUCTURE OF THE YC-17-BOUND PIKC D50N MUTANT
198, 1jipA, 0.8602, 3.05, 0.300, 403, 387, P450ERYF(A245S)/KETOCONAZOLE
199, 5yswA, 0.8600, 2.50, 0.293, 374, 372, CRYSTAL STRUCTURE ANALYSIS OF RIF16 IN COMPLEX WITH R-L 
200, 5cjeA, 0.8600, 2.77, 0.311, 390, 380, STRUCTURE OF CYP107L2
201, 1uedB, 0.8600, 2.38, 0.267, 391, 374, CRYSTAL STRUCTURE OF OXYC A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE C-C COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS.
202, 1jinA, 0.8600, 3.01, 0.301, 403, 386, P450ERYF/KETOCONAZOLE
203, 2c6hA, 0.8599, 2.90, 0.293, 393, 386, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
204, 1z8qA, 0.8598, 3.11, 0.298, 403, 389, FERROUS DIOXYGEN COMPLEX OF THE A245T CYTOCHROME P450ERYF
205, 4jx1E, 0.8596, 2.53, 0.228, 405, 378, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
206, 2vzmA, 0.8596, 2.97, 0.288, 395, 389, CRYSTAL STRUCTURE OF THE NARBOMYCIN-BOUND PIKC D50N MUTANT
207, 5ex6A, 0.8595, 2.70, 0.288, 386, 378, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
208, 2whwB, 0.8595, 3.01, 0.288, 393, 389, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
209, 2c6hB, 0.8595, 3.01, 0.290, 394, 389, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
210, 5fygA, 0.8594, 2.81, 0.256, 422, 383, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI IN COMPLEX WITH HYDROXYDODECANOIC ACID
211, 5cweA, 0.8594, 2.73, 0.310, 393, 378, STRUCTURE OF CYP107L2 FROM STREPTOMYCES AVERMITILIS WITH LAURIC ACID
212, 3g5fA, 0.8593, 2.99, 0.244, 394, 386, CRYSTALLOGRAPHIC ANALYSIS OF CYTOCHROME P450 CYP121
213, 5ofqD, 0.8592, 2.42, 0.272, 387, 372, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
214, 5ofqA, 0.8592, 2.45, 0.266, 386, 372, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
215, 4jx1F, 0.8592, 2.55, 0.225, 405, 378, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
216, 3p6sA, 0.8592, 2.46, 0.229, 404, 376, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-C8-DANS
217, 1uedA, 0.8592, 2.55, 0.265, 391, 377, CRYSTAL STRUCTURE OF OXYC A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE C-C COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS.
218, 5ibjA, 0.8591, 2.98, 0.246, 393, 386, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 6
219, 2whwA, 0.8590, 3.00, 0.290, 396, 389, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
220, 4ipwA, 0.8589, 2.99, 0.246, 394, 386, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
221, 4bf4G, 0.8589, 2.97, 0.286, 396, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
222, 4g46A, 0.8588, 3.00, 0.244, 394, 386, STRUCTURE OF CYTOCHROME P450 CYP121 IN COMPLEX WITH 4-OXO-4567- TETRAHYDROBENZOFURAN-3-CARBOXYLATE
223, 3g5hA, 0.8588, 2.99, 0.244, 394, 386, CRYSTALLOGRAPHIC ANALYSIS OF CYTOCHROME P450 CYP121
224, 5fygB, 0.8587, 2.85, 0.255, 419, 384, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI IN COMPLEX WITH HYDROXYDODECANOIC ACID
225, 4ktkA, 0.8587, 2.99, 0.246, 394, 386, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(3-AMINO-4-(4-HYDROXYPHENYL)-1H-PYRAZOL-5-YL)BENZENE-13-DIOL
226, 4iq9A, 0.8587, 3.00, 0.246, 394, 386, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
227, 4g48A, 0.8587, 2.99, 0.244, 394, 386, STRUCTURE OF CYP121 IN COMPLEX WITH 4-(4-PHENOXY-1H-PYRAZOL-3-YL) BENZENE-13-DIOL
228, 5fyfA, 0.8586, 2.82, 0.256, 420, 383, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI
229, 4bf4N, 0.8586, 3.01, 0.290, 397, 389, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
230, 4bf4L, 0.8586, 3.02, 0.290, 397, 389, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
231, 3zk5B, 0.8586, 2.93, 0.293, 394, 386, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO)ETHANOATE ANCHORING GROUP
232, 3iw2A, 0.8586, 2.57, 0.260, 398, 377, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH ECONAZOLE
233, 4ktlA, 0.8585, 3.00, 0.244, 394, 386, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(3-((4-HYDROXYPHENYL)AMINO)-1H-PYRAZOLE-45-DIYL)DIPHENOL
234, 4ipsA, 0.8585, 3.00, 0.246, 394, 386, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
235, 2wh8A, 0.8585, 2.87, 0.253, 392, 383, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
236, 1n40A, 0.8585, 3.00, 0.244, 394, 386, ATOMIC STRUCTURE OF CYP121 A MYCOBACTERIAL P450
237, 5wp2A, 0.8584, 2.99, 0.246, 394, 386, 1.44 ANGSTROM CRYSTAL STRUCTURE OF CYP121 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH SUBSTRATE AND CN 
238, 5o4kA, 0.8584, 3.00, 0.244, 394, 386, CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH COMPOUND 6B.
239, 5ex6C, 0.8584, 2.68, 0.291, 388, 378, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
240, 4g47A, 0.8584, 3.00, 0.244, 394, 386, STRUCTURE OF CYTOCHROME P450 CYP121 IN COMPLEX WITH 4-(1H-124- TRIAZOL-1-YL)PHENOL
241, 4g2gA, 0.8584, 3.00, 0.244, 394, 386, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(1H-123-TRIAZOLE-15-DIYL)DIPHENOL
242, 3p6tA, 0.8584, 2.55, 0.225, 404, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-C8-DANS
243, 4g45A, 0.8583, 3.00, 0.244, 394, 386, STRUCTURE OF CYTOCHROME CYP121 IN COMPLEX WITH 2-METHYLQUINOLIN-6- AMINE
244, 3zpiB, 0.8582, 2.93, 0.293, 396, 386, PIKC D50N MUTANT IN P21 SPACE GROUP
245, 1q5eA, 0.8582, 3.09, 0.225, 404, 387, SUBSTRATE-FREE CYTOCHROME P450EPOK
246, 5ibhA, 0.8581, 3.00, 0.244, 393, 386, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 26H
247, 4l0eA, 0.8581, 2.90, 0.249, 440, 385, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS (HEME-COORDINATED EXPRESSION TAG)
248, 4iq7A, 0.8581, 2.93, 0.247, 394, 385, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
249, 4ictA, 0.8581, 2.93, 0.244, 394, 385, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
250, 4bf4M, 0.8581, 3.01, 0.286, 397, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
251, 4bf4B, 0.8581, 2.98, 0.286, 397, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
252, 3mgxA, 0.8581, 2.70, 0.235, 387, 379, CRYSTAL STRUCTURE OF P450 OXYD THAT IS INVOLVED IN THE BIOSYNTHESIS OF VANCOMYCIN-TYPE ANTIBIOTICS
253, 5op9A, 0.8580, 3.00, 0.244, 394, 386, THE CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND 7E
254, 5ibeA, 0.8580, 3.01, 0.244, 394, 386, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 25A
255, 1n4gA, 0.8580, 2.86, 0.240, 392, 383, STRUCTURE OF CYP121 A MYCOBACTERIAL P450 IN COMPLEX WITH IODOPYRAZOLE
256, 4ktjA, 0.8579, 3.01, 0.244, 394, 386, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(3-AMINO-1H-PYRAZOL-4-YL)PHENOL
257, 4g44A, 0.8579, 3.01, 0.244, 394, 386, STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND MB286 3-((1H- 124-TRIAZOL-1-YL)METHYL)ANILINE
258, 4bf4D, 0.8579, 3.02, 0.290, 397, 389, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
259, 5ibdA, 0.8578, 3.00, 0.244, 394, 386, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 24A
260, 3rwlA, 0.8578, 2.91, 0.267, 404, 382, STRUCTURE OF P450PYR HYDROXYLASE
261, 3cxvA, 0.8578, 3.01, 0.241, 394, 386, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 A233G MUTANT FROM MYCOBACTERIUM TUBERCULOSIS
262, 1rf9A, 0.8578, 2.55, 0.225, 404, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-4-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-BUTYL-AMIDE)
263, 5opaA, 0.8577, 3.01, 0.244, 393, 386, THE CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND 7B
264, 5ibiA, 0.8577, 3.01, 0.244, 393, 386, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 26A
265, 3cxzA, 0.8577, 3.01, 0.244, 394, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 R386L MUTANT FROM M. TUBERCULOSIS
266, 1z8oA, 0.8577, 3.14, 0.296, 402, 389, FERROUS DIOXYGEN COMPLEX OF THE WILD-TYPE CYTOCHROME P450ERYF
267, 5cweB, 0.8576, 2.76, 0.310, 393, 378, STRUCTURE OF CYP107L2 FROM STREPTOMYCES AVERMITILIS WITH LAURIC ACID
268, 4pxhC, 0.8576, 2.87, 0.253, 409, 383, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
269, 4bf4A, 0.8576, 3.02, 0.290, 396, 389, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
270, 3cxxA, 0.8576, 3.01, 0.241, 394, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 F338H FROM M. TUBERCULOSIS
271, 5ikiB, 0.8575, 2.95, 0.275, 399, 382, CYP106A2 WITH SUBSTRATE ABIETIC ACID
272, 5edtA, 0.8575, 2.94, 0.244, 394, 385, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH LIG9
273, 4jwuB, 0.8575, 2.49, 0.231, 403, 376, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
274, 4b7dB, 0.8575, 2.97, 0.295, 393, 386, PIKC BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO) PROPANOATE ANCHORING GROUP
275, 3cxyA, 0.8575, 3.01, 0.246, 393, 386, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 P346L MUTANT FROM M. TUBERCULOSIS
276, 3p6qA, 0.8573, 2.51, 0.227, 401, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-ETG-BOC
277, 1pkfA, 0.8573, 2.94, 0.223, 403, 385, CRYSTAL STRUCTURE OF EPOTHILONE D-BOUND CYTOCHROME P450EPOK
278, 2cd8B, 0.8572, 2.98, 0.286, 392, 388, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
279, 5ex8A, 0.8571, 2.83, 0.254, 414, 378, STRUCTURE OF P450 STAF FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS; ETHYLENE GLYCOL CRYO
280, 4ktfA, 0.8571, 3.02, 0.244, 392, 386, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(3-AMINO-1H-PYRAZOLE-45-DIYL)DIPHENOL
281, 4g1xA, 0.8571, 3.02, 0.244, 394, 386, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(1H-124-TRIAZOL-1-YL)QUINOLIN-6-AMINE
282, 3ivyA, 0.8571, 2.59, 0.257, 399, 377, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 P212121 CRYSTAL FORM
283, 2wh8B, 0.8571, 2.90, 0.248, 392, 383, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
284, 4b7sB, 0.8570, 3.02, 0.286, 393, 388, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN- DIMETHYLAMINO)PROPANOATE ANCHORING GROUP
285, 3iw1A, 0.8570, 2.55, 0.258, 398, 376, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH ANDROSTENEDIONE
286, 3cy0A, 0.8568, 2.95, 0.244, 394, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 S237A MUTANT FROM MYCOBACTERIUM TUBERCULOSIS
287, 2xbkA, 0.8568, 3.09, 0.269, 391, 386, X-RAY STRUCTURE OF THE SUBSTRATE-BOUND CYTOCHROME P450 PIMD - A POLYENE MACROLIDE ANTIBIOTIC PIMARICIN EPOXIDASE
288, 2ij5A, 0.8568, 3.01, 0.244, 392, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
289, 5o4lA, 0.8566, 2.99, 0.242, 393, 385, CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH COMPOUND 6A.
290, 4bf4E, 0.8566, 3.03, 0.288, 397, 389, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
291, 2wh8C, 0.8566, 2.79, 0.255, 388, 381, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
292, 2bvjA, 0.8565, 2.97, 0.293, 394, 386, LIGAND-FREE STRUCTURE OF CYTOCHROME P450 PIKC (CYP107L1)
293, 3bdzB, 0.8564, 2.72, 0.202, 397, 377, THE ROLE OF ASN 242 IN P450CIN
294, 5ibfA, 0.8563, 3.02, 0.246, 393, 386, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 19A
295, 3be0A, 0.8563, 2.69, 0.199, 397, 377, THE ROLE OF ASN 242 IN P450CIN
296, 3cy1A, 0.8562, 3.03, 0.246, 394, 386, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 S279A MUTANT FROM M. TUBERCULOSIS
297, 2ij7A, 0.8562, 2.98, 0.252, 391, 385, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
298, 2ca0A, 0.8562, 3.05, 0.290, 393, 389, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC ( CYP107L1)
299, 4bf4F, 0.8561, 3.02, 0.286, 396, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
300, 4bf4H, 0.8560, 3.04, 0.288, 396, 389, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
301, 5ex9A, 0.8558, 2.84, 0.254, 414, 378, STRUCTURE OF P450 STAF FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS; GLYCEROL CRYO
302, 3be0B, 0.8558, 2.83, 0.200, 397, 380, THE ROLE OF ASN 242 IN P450CIN
303, 1z8pA, 0.8556, 3.16, 0.296, 403, 389, FERROUS DIOXYGEN COMPLEX OF THE A245S CYTOCHROME P450ERYF
304, 3tktA, 0.8555, 3.06, 0.238, 411, 387, CRYSTAL STRUCTURE OF CYP108D1 FROM NOVOSPHINGOBIUM AROMATICIVORANS DSM12444
305, 5xjnA, 0.8553, 3.21, 0.251, 403, 386, CYTOCHROME P450 CREJ IN COMPLEX WITH (4-ETHYLPHENYL) DIHYDROGEN PHOSPHATE
306, 2wh8D, 0.8553, 2.93, 0.249, 389, 382, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
307, 3p3oA, 0.8552, 2.90, 0.262, 416, 378, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERMII) FROM STREPTOMYCES THIOLUTEUS
308, 1q5dA, 0.8552, 2.93, 0.224, 401, 384, EPOTHILONE B-BOUND CYTOCHROME P450EPOK
309, 5ofqB, 0.8549, 2.51, 0.272, 386, 372, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
310, 4bf4J, 0.8549, 3.08, 0.288, 397, 389, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
311, 2ij7E, 0.8549, 2.98, 0.252, 391, 385, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
312, 4tx3A, 0.8548, 2.53, 0.293, 373, 372, COMPLEX OF THE X-DOMAIN AND OXYB FROM TEICOPLANIN BIOSYNTHESIS
313, 2yooB, 0.8548, 2.71, 0.257, 395, 377, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
314, 4fmxA, 0.8547, 2.82, 0.197, 397, 380, CRYSTAL STRUCTURE OF SUBSTRATE-BOUND P450CIN
315, 5gnlA, 0.8546, 2.94, 0.323, 395, 381, CYTOCHROME P450 VDH (CYP107BR1) F106V MUTANT
316, 3bdzA, 0.8546, 2.73, 0.199, 397, 377, THE ROLE OF ASN 242 IN P450CIN
317, 2xc3A, 0.8545, 2.70, 0.261, 409, 379, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP125 BOUND TO THE REVERSE TYPE I INHIBITOR
318, 2ij5B, 0.8545, 3.01, 0.244, 390, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
319, 5ofqC, 0.8542, 2.51, 0.272, 386, 372, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
320, 5hh3A, 0.8542, 2.58, 0.266, 381, 372, OXYA FROM ACTINOPLANES TEICHOMYCETICUS
321, 3p6uA, 0.8542, 2.50, 0.229, 402, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-C6-DANS
322, 3bujA, 0.8542, 2.90, 0.266, 397, 380, CRYSTAL STRUCTURE OF CALO2
323, 2ij5C, 0.8541, 3.03, 0.246, 394, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
324, 4bf4K, 0.8540, 3.08, 0.286, 397, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
325, 2yooC, 0.8540, 2.73, 0.257, 395, 377, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
326, 2ij7B, 0.8539, 3.01, 0.252, 391, 385, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
327, 5ex6B, 0.8538, 2.32, 0.298, 371, 369, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
328, 2ij7D, 0.8538, 3.01, 0.252, 391, 385, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
329, 4l77B, 0.8537, 2.74, 0.199, 397, 377, P450CIN ACTIVE SITE WATER: IMPLICATIONS FOR SUBSTRATE BINDING AND SOLVENT ACCESSIBILITY
330, 5gweC, 0.8536, 3.29, 0.248, 405, 387, CYTOCHROME P450 CREJ
331, 4fmxB, 0.8536, 2.84, 0.197, 397, 380, CRYSTAL STRUCTURE OF SUBSTRATE-BOUND P450CIN
332, 2c7xA, 0.8536, 3.06, 0.286, 396, 388, CRYSTAL STRUCTURE OF NARBOMYCIN-BOUND CYTOCHROME P450 PIKC (CYP107L1)
333, 4l77A, 0.8535, 2.72, 0.202, 396, 376, P450CIN ACTIVE SITE WATER: IMPLICATIONS FOR SUBSTRATE BINDING AND SOLVENT ACCESSIBILITY
334, 2ij7C, 0.8535, 3.00, 0.252, 391, 385, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
335, 4bf4I, 0.8533, 3.09, 0.284, 396, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
336, 4fyzA, 0.8531, 2.84, 0.197, 397, 380, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CIN
337, 3zpiA, 0.8531, 3.03, 0.290, 396, 386, PIKC D50N MUTANT IN P21 SPACE GROUP
338, 1t2bA, 0.8529, 2.85, 0.197, 397, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450CIN COMPLEXED WITH ITS SUBSTRATE 18-CINEOLE
339, 5ibgA, 0.8527, 2.92, 0.253, 390, 383, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 25B
340, 4lhtA, 0.8527, 2.86, 0.197, 396, 380, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 3 MM 18- CINEOLE
341, 2ij5D, 0.8527, 3.03, 0.249, 391, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
342, 3a4gA, 0.8526, 2.83, 0.327, 395, 379, STRUCTURE OF CYTOCHROME P450 VDH FROM PSEUDONOCARDIA AUTOTROPHICA (TRIGONAL CRYSTAL FORM)
343, 5gweD, 0.8525, 3.18, 0.249, 403, 385, CYTOCHROME P450 CREJ
344, 4l6gB, 0.8525, 2.86, 0.197, 397, 380, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 7 MM 18- CINEOLE
345, 3zk5A, 0.8525, 3.03, 0.290, 397, 386, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO)ETHANOATE ANCHORING GROUP
346, 2ij7F, 0.8525, 3.03, 0.252, 391, 385, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
347, 5gweA, 0.8523, 3.31, 0.248, 405, 387, CYTOCHROME P450 CREJ
348, 4lhtB, 0.8523, 2.87, 0.197, 396, 380, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 3 MM 18- CINEOLE
349, 4triB, 0.8522, 2.75, 0.257, 400, 377, X-RAY CRYSTAL STRUCTURE OF CYP142A2 FROM MYCOBACTERIUM SMEGMATIS COMPLEXED WITH CHOLESTEROL SULFATE.
350, 4b7dA, 0.8522, 3.12, 0.290, 393, 389, PIKC BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO) PROPANOATE ANCHORING GROUP
351, 5hdiA, 0.8521, 2.78, 0.205, 397, 381, STRUCTURAL CHARACTERIZATION OF CYP144A1 A MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450
352, 2yooD, 0.8520, 2.69, 0.258, 394, 376, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
353, 4b7sA, 0.8519, 3.04, 0.293, 397, 386, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN- DIMETHYLAMINO)PROPANOATE ANCHORING GROUP
354, 1t2bB, 0.8519, 2.85, 0.197, 397, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450CIN COMPLEXED WITH ITS SUBSTRATE 18-CINEOLE
355, 4dxyA, 0.8518, 2.67, 0.185, 406, 379, CRYSTAL STRUCTURES OF CYP101D2 Y96A MUTANT
356, 3p6pA, 0.8518, 2.70, 0.222, 407, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C6-BIO
357, 4l6gA, 0.8516, 2.87, 0.197, 397, 380, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 7 MM 18- CINEOLE
358, 4fyzB, 0.8516, 2.86, 0.197, 397, 380, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CIN
359, 4triA, 0.8515, 2.77, 0.257, 401, 377, X-RAY CRYSTAL STRUCTURE OF CYP142A2 FROM MYCOBACTERIUM SMEGMATIS COMPLEXED WITH CHOLESTEROL SULFATE.
360, 2cd8A, 0.8515, 2.96, 0.289, 391, 384, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
361, 2yooA, 0.8514, 2.78, 0.257, 396, 377, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
362, 4bf4C, 0.8513, 3.08, 0.286, 396, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
363, 3p6rA, 0.8513, 2.41, 0.229, 398, 371, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG 3OH-ADAC1-ETG-BOC
364, 5xntA, 0.8505, 2.73, 0.293, 392, 375, STRUCTURE OF CYP106A2 FROM BACILLUS SP. PAMC 23377
365, 3ejbH, 0.8503, 3.09, 0.294, 387, 377, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
366, 2ca0B, 0.8503, 3.05, 0.293, 393, 386, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC ( CYP107L1)
367, 3p6wA, 0.8500, 2.49, 0.225, 400, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-ETG-BOC
368, 3p6vA, 0.8497, 2.42, 0.226, 398, 371, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG 3ET-ADAC1-ETG-BOC
369, 3ol5A, 0.8496, 2.74, 0.222, 405, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED WITH A TETHERED SUBSTRATE ANALOG 3OH-ADAC1-C8-DANS
370, 4y8wA, 0.8495, 2.94, 0.173, 440, 382, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
371, 5l90B, 0.8494, 2.51, 0.287, 385, 369, THE CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109E1 FROM BACILLUS MEGATERIUM AT 2.55 ANGSTROM RESOLUTION
372, 3vrmA, 0.8492, 3.01, 0.323, 402, 378, STRUCTURE OF CYTOCHROME P450 VDH MUTANT T107A WITH BOUND VITAMIN D3
373, 3p6mA, 0.8492, 2.75, 0.222, 404, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8-DANS
374, 4y8wB, 0.8486, 2.99, 0.172, 440, 383, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
375, 3p6nA, 0.8485, 2.76, 0.222, 404, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8-DANS
376, 3nv6A, 0.8485, 2.80, 0.182, 404, 380, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D2
377, 5vbuB, 0.8484, 3.03, 0.175, 441, 383, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
378, 2xkrA, 0.8484, 2.80, 0.253, 395, 376, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP142: A NOVEL CHOLESTEROL OXIDASE
379, 5vwsA, 0.8482, 2.28, 0.288, 376, 365, LIGAND FREE STRUCTURE OF CYTOCHROME P450 TBTJ1
380, 2xfhA, 0.8482, 2.86, 0.277, 394, 376, STRUCTURE OF CYTOCHROME P450 ERYK COCRYSTALLIZED WITH INHIBITOR CLOTRIMAZOLE.
381, 3p6oA, 0.8481, 2.77, 0.222, 405, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-ETG-DANS
382, 3a51D, 0.8480, 3.10, 0.325, 402, 382, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
383, 3wriB, 0.8479, 2.55, 0.225, 403, 374, CRYSTAL STRUCTURE OF P450CAM
384, 3wriA, 0.8479, 2.55, 0.225, 403, 374, CRYSTAL STRUCTURE OF P450CAM
385, 3a4zD, 0.8479, 3.11, 0.325, 401, 382, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
386, 3l62A, 0.8478, 2.52, 0.223, 400, 373, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CAM AT LOW [K+]
387, 5h1zA, 0.8477, 3.08, 0.254, 400, 382, CYP153D17 FROM SPHINGOMONAS SP. PAMC 26605
388, 3ejeD, 0.8477, 2.97, 0.297, 385, 374, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
389, 5vbuC, 0.8475, 3.04, 0.175, 442, 383, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
390, 1lwlA, 0.8475, 2.77, 0.222, 404, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-8-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-OCTYL-AMIDE)
391, 5ysmA, 0.8474, 2.17, 0.298, 364, 362, CRYSTAL STRUCTURE ANALYSIS OF RIF16 
392, 3a4zE, 0.8474, 3.04, 0.325, 401, 379, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
393, 3a4zB, 0.8473, 3.05, 0.325, 402, 379, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
394, 3oiaA, 0.8472, 2.78, 0.222, 405, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8GLUETG-BIO
395, 1re9A, 0.8472, 2.77, 0.222, 404, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-8-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-OCTYL-AMIDE)
396, 5vbuA, 0.8471, 3.05, 0.175, 442, 383, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
397, 4y8wC, 0.8471, 3.04, 0.175, 442, 383, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
398, 3a50D, 0.8469, 3.12, 0.325, 401, 382, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
399, 3a50B, 0.8469, 3.05, 0.325, 402, 379, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
400, 2ij5F, 0.8469, 2.94, 0.247, 384, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
401, 3ejdD, 0.8468, 2.99, 0.297, 385, 374, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
402, 3a51C, 0.8468, 3.19, 0.324, 401, 383, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
403, 3a51B, 0.8468, 3.15, 0.325, 402, 382, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
404, 5l91A, 0.8467, 2.78, 0.284, 391, 373, THE 2.2 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM BOUND WITH FOUR CORTICOSTERONE MOLECULES
405, 3ejbD, 0.8466, 3.15, 0.295, 386, 376, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
406, 3a51E, 0.8465, 3.14, 0.325, 401, 382, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
407, 3a4zC, 0.8465, 3.14, 0.325, 401, 382, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
408, 3nv5A, 0.8459, 2.74, 0.183, 399, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D2
409, 3a50E, 0.8459, 3.06, 0.325, 401, 379, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
410, 2ij5E, 0.8459, 2.95, 0.242, 387, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
411, 5l90A, 0.8457, 2.57, 0.287, 385, 369, THE CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109E1 FROM BACILLUS MEGATERIUM AT 2.55 ANGSTROM RESOLUTION
412, 3a50C, 0.8457, 3.15, 0.325, 401, 382, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
413, 3ejdB, 0.8456, 2.93, 0.298, 382, 372, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
414, 2z3tA, 0.8455, 2.79, 0.273, 385, 373, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
415, 4yt3A, 0.8452, 2.67, 0.277, 388, 372, CYP106A2
416, 4pwvA, 0.8452, 2.94, 0.253, 404, 379, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
417, 4jwsB, 0.8451, 2.48, 0.224, 395, 370, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
418, 5fyfB, 0.8450, 2.77, 0.261, 411, 376, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI
419, 3p6xA, 0.8450, 2.52, 0.231, 399, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-C8-DANS
420, 5m0pB, 0.8449, 2.97, 0.137, 421, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET F79A IN COMPLEX WITH ARACHIDONIC ACID
421, 5hdiB, 0.8447, 2.75, 0.207, 393, 377, STRUCTURAL CHARACTERIZATION OF CYP144A1 A MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450
422, 3qz1A, 0.8446, 3.04, 0.147, 445, 381, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
423, 5m0nA, 0.8445, 2.97, 0.137, 423, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET IN COMPLEX WITH FORMATE
424, 2uvnA, 0.8445, 3.28, 0.246, 399, 386, CRYSTAL STRUCTURE OF ECONAZOLE-BOUND CYP130 FROM MYCOBACTERIUM TUBERCULOSIS
425, 5l91B, 0.8444, 2.73, 0.285, 389, 372, THE 2.2 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM BOUND WITH FOUR CORTICOSTERONE MOLECULES
426, 4l54A, 0.8444, 2.98, 0.137, 419, 379, STRUCTURE OF CYTOCHROME P450 OLET LIGAND-FREE
427, 3ejdH, 0.8443, 2.97, 0.298, 382, 372, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
428, 5m0pA, 0.8440, 3.00, 0.137, 424, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET F79A IN COMPLEX WITH ARACHIDONIC ACID
429, 5m0oA, 0.8440, 2.98, 0.137, 419, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET H85Q IN COMPLEX WITH ARACHIDONIC ACID
430, 3a50A, 0.8438, 3.07, 0.325, 402, 379, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
431, 3r9bC, 0.8435, 2.86, 0.267, 391, 375, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
432, 3a51A, 0.8435, 3.18, 0.325, 402, 382, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
433, 4l40A, 0.8434, 3.00, 0.137, 419, 379, STRUCTURE OF THE P450 OLET WITH A C20 FATTY ACID SUBSTRATE BOUND
434, 3r9bB, 0.8434, 2.86, 0.267, 391, 375, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
435, 3r9bA, 0.8434, 2.86, 0.267, 391, 375, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
436, 1lg9A, 0.8432, 2.51, 0.271, 377, 369, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
437, 3a4zA, 0.8431, 3.19, 0.325, 402, 382, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
438, 6fshD, 0.8429, 2.80, 0.278, 382, 374, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
439, 3ejeF, 0.8426, 2.91, 0.300, 380, 370, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
440, 5m0oC, 0.8425, 3.09, 0.139, 421, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET H85Q IN COMPLEX WITH ARACHIDONIC ACID
441, 5lieB, 0.8425, 3.10, 0.277, 397, 379, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH IMIDAZOLE
442, 1lgfA, 0.8425, 3.11, 0.266, 388, 379, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
443, 2z3tC, 0.8423, 2.78, 0.275, 383, 371, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
444, 5ikiA, 0.8422, 2.56, 0.276, 383, 369, CYP106A2 WITH SUBSTRATE ABIETIC ACID
445, 3ejeH, 0.8422, 3.01, 0.298, 383, 372, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
446, 5omuA, 0.8421, 2.81, 0.215, 402, 376, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH SYRINGOL 
447, 5omrA, 0.8419, 2.89, 0.215, 403, 377, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH VANILLIN. 
448, 3ejdF, 0.8419, 2.97, 0.299, 381, 371, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
449, 5omsA, 0.8416, 2.89, 0.212, 403, 377, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH GUAETHOL. 
450, 4yt3B, 0.8412, 2.71, 0.277, 388, 372, CYP106A2
451, 3wecA, 0.8408, 3.05, 0.243, 401, 379, STRUCTURE OF P450 RAUA (CYP1050A1) COMPLEXED WITH A BIOSYNTHETIC INTERMEDIATE OF AURACHIN RE
452, 5wk9A, 0.8399, 2.83, 0.211, 405, 375, R186AP450CAM WITH CN AND CAMPHOR
453, 5wk7A, 0.8398, 2.84, 0.213, 405, 375, P450CAM MUTANT R186A
454, 3qz1C, 0.8395, 2.98, 0.149, 437, 377, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
455, 3qz1B, 0.8395, 2.83, 0.149, 436, 375, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
456, 3ofuB, 0.8395, 2.89, 0.218, 396, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
457, 5ik1A, 0.8394, 2.49, 0.226, 394, 367, OPEN STATE OF P450CAM AFTER SOAKING IN CAMPHOR
458, 4fb2A, 0.8394, 2.69, 0.209, 392, 374, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
459, 3oftA, 0.8394, 2.90, 0.218, 396, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
460, 3ejbB, 0.8394, 2.78, 0.297, 380, 367, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
461, 1izoA, 0.8394, 2.99, 0.135, 411, 378, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
462, 4ep6A, 0.8393, 2.85, 0.219, 392, 374, CRYSTAL STRUCTURE OF THE XPLA HEME DOMAIN IN COMPLEX WITH IMIDAZOLE AND PEG
463, 4z5qA, 0.8392, 2.13, 0.299, 363, 358, CRYSTAL STRUCTURE OF THE LNMZ CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.8 A RESOLUTION
464, 6fshA, 0.8391, 2.61, 0.278, 378, 370, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
465, 3qz1D, 0.8390, 2.94, 0.149, 434, 377, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
466, 3ofuC, 0.8389, 2.90, 0.218, 396, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
467, 3ejbF, 0.8387, 2.91, 0.299, 378, 368, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
468, 3vtjA, 0.8386, 2.98, 0.114, 407, 378, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT A245H
469, 3vooA, 0.8386, 2.98, 0.116, 407, 378, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT A245E
470, 2fr7A, 0.8386, 2.80, 0.226, 397, 371, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP199A2
471, 3l61A, 0.8385, 2.53, 0.225, 396, 369, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CAM AT 200 MM [K+]
472, 3awqA, 0.8385, 2.98, 0.116, 407, 378, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT L78F
473, 2wivB, 0.8385, 2.93, 0.224, 391, 375, CYTOCHROME-P450 XPLA HEME DOMAIN P21
474, 3vnoA, 0.8383, 2.99, 0.119, 407, 378, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT R241E
475, 3ofuA, 0.8383, 2.91, 0.218, 396, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
476, 2wiyA, 0.8383, 2.92, 0.221, 394, 375, CYTOCHROME P450 XPLA HEME DOMAIN P21212
477, 2wivA, 0.8383, 2.91, 0.235, 391, 375, CYTOCHROME-P450 XPLA HEME DOMAIN P21
478, 3vm4A, 0.8381, 2.99, 0.119, 407, 378, CYTOCHROME P450SP ALPHA (CYP152B1) IN COMPLEX WITH (R)-IBUPROPHEN
479, 3ejeB, 0.8379, 2.87, 0.297, 378, 367, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
480, 2wioA, 0.8379, 2.97, 0.275, 393, 374, STRUCTURE OF THE  HISTIDINE TAGGED OPEN CYTOCHROME P450 ERYK FROM S. ERYTHRAEA
481, 3awpA, 0.8375, 3.00, 0.116, 407, 378, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT F288G
482, 3awmA, 0.8372, 3.01, 0.116, 407, 378, CYTOCHROME P450SP ALPHA (CYP152B1) WILD-TYPE WITH PALMITIC ACID
483, 2x80B, 0.8371, 3.22, 0.126, 455, 381, P450 BM3 F87A IN COMPLEX WITH DMSO
484, 2jjoA, 0.8370, 3.02, 0.271, 393, 373, STRUCTURE OF CYTOCHROME P450 ERYK IN COMPLEX WITH ITS NATURAL SUBSTRATE ERD
485, 2zqxC, 0.8368, 3.05, 0.138, 411, 378, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
486, 2uvnB, 0.8368, 3.17, 0.250, 391, 380, CRYSTAL STRUCTURE OF ECONAZOLE-BOUND CYP130 FROM MYCOBACTERIUM TUBERCULOSIS
487, 1izoC, 0.8366, 3.03, 0.135, 411, 378, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
488, 3ofuD, 0.8365, 2.86, 0.220, 394, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
489, 5hh3C, 0.8363, 2.97, 0.272, 393, 375, OXYA FROM ACTINOPLANES TEICHOMYCETICUS
490, 3ekbB, 0.8363, 3.22, 0.121, 457, 380, CRYSTAL STRUCTURE OF THE A264C MUTANT HEME DOMAIN OF CYTOCHROME P450 BM3
491, 4ek1B, 0.8361, 2.91, 0.219, 404, 375, CRYSTAL STRUCTURE OF ELECTRON-SPIN LABELED CYTOCHROME P450CAM
492, 5l92A, 0.8359, 2.76, 0.280, 386, 368, THE 2.1 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH CORTICOSTERONE
493, 2z3tD, 0.8359, 2.78, 0.277, 379, 368, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
494, 2x80A, 0.8358, 3.24, 0.123, 455, 381, P450 BM3 F87A IN COMPLEX WITH DMSO
495, 1dz8B, 0.8357, 2.93, 0.219, 405, 375, OXYGEN COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
496, 4l4gA, 0.8356, 2.92, 0.219, 405, 375, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358P/K178G
497, 3oftB, 0.8355, 2.85, 0.220, 393, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
498, 5gweB, 0.8354, 3.29, 0.243, 396, 378, CYTOCHROME P450 CREJ
499, 6fshB, 0.8353, 2.76, 0.278, 380, 371, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
500, 2zqjC, 0.8353, 2.99, 0.138, 411, 377, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
501, 2zqjB, 0.8353, 3.04, 0.135, 411, 378, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
502, 4jwsA, 0.8352, 2.48, 0.227, 392, 366, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
503, 3l63A, 0.8350, 2.92, 0.216, 405, 375, CRYSTAL STRUCTURE OF CAMPHOR-BOUND P450CAM AT LOW [K+]
504, 1dz9B, 0.8350, 2.94, 0.219, 405, 375, PUTATIVE OXO COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
505, 2zqxA, 0.8349, 3.01, 0.138, 411, 377, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
506, 1t86A, 0.8349, 2.93, 0.219, 406, 375, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM MUTANT (L358P/C334A)
507, 1t87A, 0.8348, 2.94, 0.219, 407, 375, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM (C334A)
508, 4l49A, 0.8347, 2.93, 0.219, 405, 375, STRUCTURE OF L358A MUTANT OF P450CAM BOUND TO CAMPHOR
509, 2zqxB, 0.8347, 3.05, 0.135, 411, 378, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
510, 2x9pA, 0.8347, 2.95, 0.277, 385, 376, X-RAY STRUCTURE OF THE SUBSTRATE-FREE CYTOCHROME P450 PIMD - A POLYENE MACROLIDE ANTIBIOTIC PIMARICIN EPOXIDASE
511, 1o76B, 0.8347, 2.95, 0.219, 405, 375, CYANIDE COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
512, 5l94A, 0.8346, 2.81, 0.277, 385, 368, THE 2.25 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH TESTOSTERONE
513, 2a1oA, 0.8346, 2.95, 0.213, 405, 375, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF T252A CYTOCHROME P450CAM
514, 2zqjA, 0.8344, 3.02, 0.135, 411, 377, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
515, 2hi4A, 0.8343, 3.19, 0.151, 480, 385, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 1A2 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
516, 3czhB, 0.8342, 3.25, 0.143, 467, 385, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D2
517, 2gr6A, 0.8342, 2.95, 0.211, 405, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A)
518, 1j51A, 0.8342, 2.95, 0.216, 405, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
519, 6fshC, 0.8340, 2.82, 0.280, 380, 371, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
520, 4l4fA, 0.8340, 2.96, 0.213, 405, 375, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A/K178G/D182N
521, 3r9cA, 0.8340, 3.31, 0.263, 400, 380, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 WITH ECONAZOLE BOUND
522, 2a1mA, 0.8340, 2.95, 0.219, 405, 375, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF WILD-TYPE CYTOCHROME P450CAM
523, 1uyuB, 0.8340, 2.96, 0.219, 405, 375, XENON COMPLEX OF WILDTYPE P450CAM FROM PSEUDOMONAS PUTIDA
524, 1izoB, 0.8340, 3.02, 0.138, 411, 377, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
525, 4fb2D, 0.8339, 2.79, 0.211, 391, 374, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
526, 1mpwA, 0.8339, 2.95, 0.213, 405, 375, MOLECULAR RECOGNITION IN (+)-A-PINENE OXIDATION BY CYTOCHROME P450CAM
527, 4l4eA, 0.8337, 2.96, 0.216, 405, 375, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A/K178G
528, 2a1nA, 0.8337, 2.96, 0.216, 407, 375, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF D251N CYTOCHROME P450CAM
529, 1dz6B, 0.8337, 2.96, 0.219, 405, 375, FERROUS P450CAM FROM PSEUDOMONAS PUTIDA
530, 5li8A, 0.8336, 3.04, 0.288, 390, 372, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH KETOCONAZOLE
531, 4l4dA, 0.8336, 2.97, 0.216, 405, 375, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A
532, 3dl9B, 0.8336, 3.26, 0.143, 467, 385, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH 1-ALPHA-HYDROXY- VITAMIN D2
533, 1j51C, 0.8336, 2.96, 0.216, 405, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
534, 1yqoB, 0.8335, 3.23, 0.124, 441, 380, T268A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
535, 1dz8A, 0.8335, 2.97, 0.216, 404, 375, OXYGEN COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
536, 3c6gB, 0.8334, 3.25, 0.140, 467, 385, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D3
537, 3cp4A, 0.8332, 2.96, 0.213, 405, 375, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
538, 1pheA, 0.8332, 2.97, 0.216, 405, 375, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE-INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
539, 1dz9A, 0.8332, 2.97, 0.216, 404, 375, PUTATIVE OXO COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
540, 2gqxA, 0.8331, 2.95, 0.211, 405, 374, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A) WITH PENTACHLOROBENZENE
541, 1t85A, 0.8331, 2.96, 0.219, 406, 375, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM MUTANT (L358P/C334A)
542, 1t88A, 0.8329, 2.97, 0.219, 407, 375, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM (C334A)
543, 1bu7B, 0.8329, 3.23, 0.118, 455, 380, CRYOGENIC STRUCTURE OF CYTOCHROME P450BM-3 HEME DOMAIN
544, 5jquB, 0.8328, 3.27, 0.115, 453, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
545, 3kx5B, 0.8328, 3.24, 0.124, 455, 380, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT F261E
546, 1iwkA, 0.8328, 2.97, 0.213, 405, 375, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF MUTANT(112K) CYTOCHROME P450CAM
547, 5e7yB, 0.8327, 3.28, 0.121, 452, 381, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN M7 VARIANT
548, 4duaA, 0.8327, 3.24, 0.124, 457, 380, CYTOCHROME P450 BM3H-9D7 MRI SENSOR NO LIGAND
549, 2h7qA, 0.8327, 2.96, 0.219, 405, 374, CYTOCHROME P450CAM COMPLEXED WITH IMIDAZOLE
550, 1phcA, 0.8327, 2.97, 0.216, 405, 375, CRYSTAL STRUCTURE OF SUBSTRATE-FREE PSEUDOMONAS PUTIDA CYTOCHROME P450
551, 6cppA, 0.8326, 2.97, 0.216, 405, 375, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
552, 2jjnA, 0.8326, 3.11, 0.272, 395, 375, STRUCTURE OF CLOSED CYTOCHROME P450 ERYK
553, 2feuB, 0.8326, 2.98, 0.219, 405, 375, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
554, 1t86B, 0.8326, 2.98, 0.219, 406, 375, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM MUTANT (L358P/C334A)
555, 5l92B, 0.8325, 2.39, 0.279, 370, 362, THE 2.1 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH CORTICOSTERONE
556, 2bmhB, 0.8325, 3.23, 0.126, 455, 380, MODELING PROTEIN-SUBSTRATE INTERACTIONS IN THE HEME DOMAIN OF CYTOCHROME P450BM-3
557, 1dz4B, 0.8325, 2.97, 0.219, 405, 375, FERRIC P450CAM FROM PSEUDOMONAS PUTIDA
558, 2nnbB, 0.8324, 3.23, 0.126, 441, 380, THE Q403K MUTNAT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
559, 5cp4A, 0.8323, 2.99, 0.219, 406, 375, CRYOGENIC STRUCTURE OF P450CAM
560, 4ejhG, 0.8323, 3.17, 0.173, 463, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
561, 4dubA, 0.8323, 3.24, 0.124, 456, 380, CYTOCHROME P450 BM3H-9D7 MRI SENSOR BOUND TO DOPAMINE
562, 3wrlA, 0.8323, 2.98, 0.219, 405, 375, CRYSTAL STRUCTURE OF P450CAM
563, 2hpdB, 0.8323, 3.25, 0.124, 457, 380, CRYSTAL STRUCTURE OF HEMOPROTEIN DOMAIN OF P450BM-3 A PROTOTYPE FOR MICROSOMAL P450 S
564, 2cp4A, 0.8323, 2.98, 0.213, 405, 375, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
565, 4dufD, 0.8321, 3.24, 0.118, 456, 380, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
566, 1og2A, 0.8321, 3.18, 0.154, 461, 382, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
567, 6c94A, 0.8320, 3.15, 0.128, 482, 383, STRUCTURE OF CYTOCHROME P450 4B1 (CYP4B1) COMPLEXED WITH THE INHIBITOR HET0016 
568, 6c93A, 0.8320, 3.16, 0.131, 478, 383, EFFECTS OF THE E310A MUTATION OF CYTOCHROME P450 4B1 (CYP4B1) ON N- OCTANE BINDING AND HEME RUFFLING 
569, 4l4bA, 0.8320, 2.98, 0.213, 405, 375, STRUCTURE OF L358A/K178G/D182N MUTANT OF P450CAM BOUND TO CAMPHOR
570, 4g3rA, 0.8320, 2.98, 0.216, 407, 375, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CAM
571, 1iwiA, 0.8320, 2.98, 0.216, 405, 375, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF CYTOCHROME P450CAM
572, 1fahB, 0.8320, 3.24, 0.124, 455, 380, STRUCTURE OF CYTOCHROME P450
573, 4l4aA, 0.8319, 3.00, 0.216, 405, 375, STRUCTURE OF L358A/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
574, 4kkyX, 0.8319, 3.00, 0.219, 411, 375, CRYSTAL STRUCTURE OF N-(1-PYRENE)ACETAMIDE LABELED P450CAM IN SUBSTRATE BOUND FORM.
575, 4dufA, 0.8319, 3.25, 0.116, 456, 380, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
576, 3wrhA, 0.8319, 2.98, 0.219, 405, 375, CRYSTAL STRUCTURE OF P450CAM
577, 1phaA, 0.8319, 2.98, 0.216, 405, 375, INHIBITOR-INDUCED CONFORMATIONAL CHANGE IN CYTOCHROME P450- CAM
578, 1o76A, 0.8319, 2.99, 0.219, 404, 375, CYANIDE COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
579, 6cp4A, 0.8318, 2.99, 0.213, 405, 375, P450CAM D251N MUTANT
580, 4wg2A, 0.8318, 3.25, 0.132, 461, 380, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
581, 4ek1A, 0.8318, 2.98, 0.219, 403, 374, CRYSTAL STRUCTURE OF ELECTRON-SPIN LABELED CYTOCHROME P450CAM
582, 3cppA, 0.8318, 2.98, 0.216, 405, 375, CRYSTAL STRUCTURE OF THE CARBON MONOXY-SUBSTRATE-CYTOCHROME P450-CAM TERNARY COMPLEX
583, 2frzA, 0.8318, 3.00, 0.216, 405, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A)
584, 1phbA, 0.8318, 2.98, 0.216, 405, 375, INHIBITOR-INDUCED CONFORMATIONAL CHANGE IN CYTOCHROME P450- CAM
585, 1nooA, 0.8318, 2.99, 0.216, 405, 375, CYTOCHROME P450-CAM COMPLEXED WITH 5-EXO-HYDROXYCAMPHOR
586, 4wg2C, 0.8317, 3.24, 0.126, 460, 380, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
587, 4cppA, 0.8317, 2.99, 0.216, 405, 375, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
588, 1zo4B, 0.8317, 3.24, 0.124, 457, 380, CRYSTAL STRUCTURE OF A328S MUTANT OF THE HEME DOMAIN OF P450BM-3
589, 1jmeB, 0.8317, 3.24, 0.124, 441, 380, CRYSTAL STRUCTURE OF PHE393HIS CYTOCHROME P450 BM3
590, 1iwjA, 0.8317, 2.98, 0.216, 405, 375, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF MUTANT(109K) CYTOCHROME P450CAM
591, 1akdA, 0.8317, 2.99, 0.219, 405, 375, CYTOCHROME P450CAM FROM PSEUDOMONAS PUTIDA COMPLEXED WITH 1S-CAMPHOR
592, 3czhA, 0.8316, 3.29, 0.140, 465, 385, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D2
593, 2ij3B, 0.8316, 3.25, 0.118, 454, 380, STRUCTURE OF THE A264H MUTANT OF CYTOCHROME P450 BM3
594, 2h7rA, 0.8316, 2.98, 0.208, 405, 375, L244A MUTANT OF CYTOCHROME P450CAM COMPLEXED WITH IMIDAZOLE
595, 1yqpB, 0.8316, 3.25, 0.124, 441, 380, T268N MUTANT CYTOCHROME DOMAIN OF FLAVOCYTOCHROME P450 BM3
596, 1p0xB, 0.8315, 3.25, 0.121, 448, 380, F393Y MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
597, 1p0wB, 0.8315, 3.25, 0.124, 448, 380, F393W MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
598, 1p0vB, 0.8315, 3.25, 0.121, 444, 380, F393A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
599, 1gemA, 0.8315, 2.99, 0.216, 405, 375, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
600, 5e7yA, 0.8314, 3.24, 0.121, 451, 380, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN M7 VARIANT
601, 4wg2B, 0.8314, 3.26, 0.132, 451, 380, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
602, 2ij2A, 0.8314, 3.25, 0.121, 450, 380, ATOMIC STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME P450- BM3
603, 1c8jA, 0.8314, 3.00, 0.219, 405, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F)
604, 3kx4B, 0.8313, 3.25, 0.116, 454, 380, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT I401E
605, 2cppA, 0.8313, 2.99, 0.216, 405, 375, HIGH-RESOLUTION CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM
606, 2a1oB, 0.8313, 3.00, 0.216, 405, 375, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF T252A CYTOCHROME P450CAM
607, 1phgA, 0.8313, 2.99, 0.213, 405, 375, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE- INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
608, 1cp4A, 0.8313, 2.99, 0.216, 405, 375, FORMATION CRYSTAL STRUCTURE AND REARRANGEMENT OF A CYTOCHROME P450-CAM IRON-PHENYL COMPLEX
609, 4dudA, 0.8312, 3.26, 0.124, 456, 380, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR NO LIGAND
610, 4ducA, 0.8312, 3.26, 0.118, 456, 380, CYTOCHROME P450 BM3H-2G9 MRI SENSOR NO LIGAND
611, 5e78A, 0.8311, 3.27, 0.121, 447, 380, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN VARIANT COMPLEXED WITH CO(III)SEP
612, 4cp4A, 0.8311, 3.00, 0.216, 405, 375, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
613, 3wrjA, 0.8311, 3.00, 0.219, 405, 375, CRYSTAL STRUCTURE OF P450CAM
614, 1t87B, 0.8311, 3.00, 0.219, 405, 375, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM (C334A)
615, 1phfA, 0.8311, 2.99, 0.216, 405, 375, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE- INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
616, 8cppA, 0.8310, 3.00, 0.219, 405, 375, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
617, 7cppA, 0.8310, 2.98, 0.217, 405, 374, THE STRUCTURAL BASIS FOR SUBSTRATE-INDUCED CHANGES IN REDOX POTENTIAL AND SPIN EQUILIBRIUM IN CYTOCHROME P450(CAM)
618, 4l4cA, 0.8310, 3.00, 0.216, 405, 375, STRUCTURE OF L358P/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
619, 4hgiA, 0.8309, 3.26, 0.121, 455, 380, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET II)
620, 4hghA, 0.8309, 3.26, 0.121, 455, 380, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET I)
621, 3fwgB, 0.8309, 3.00, 0.216, 405, 375, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM ARG365LEU GLU366GLN MONOCLINIC CRYSTAL FORM
622, 1og5B, 0.8309, 3.24, 0.151, 461, 383, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
623, 1gekA, 0.8309, 2.99, 0.217, 406, 374, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
624, 5og9B, 0.8308, 3.23, 0.126, 454, 380, THE BM3 MUTANT WIFI-WC HEME DOMAIN IN COMPLEX WITH TESTOSTERONE 
625, 5cppA, 0.8308, 3.00, 0.216, 405, 375, THE STRUCTURAL BASIS FOR SUBSTRATE-INDUCED CHANGES IN REDOX POTENTIAL AND SPIN EQUILIBRIUM IN CYTOCHROME P-450(CAM)
626, 3zkpA, 0.8308, 3.00, 0.270, 390, 370, STRUCTURE OF A MUTANT OF P450 ERYK IN COMPLEX WITH ERYTHROMYCIN B.
627, 3wrmA, 0.8308, 3.01, 0.219, 405, 375, CRYSTAL STRUCTURE OF P450CAM
628, 3dl9A, 0.8308, 3.30, 0.140, 465, 385, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH 1-ALPHA-HYDROXY- VITAMIN D2
629, 2a1mB, 0.8308, 3.01, 0.219, 405, 375, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF WILD-TYPE CYTOCHROME P450CAM
630, 5og9A, 0.8307, 3.24, 0.121, 454, 380, THE BM3 MUTANT WIFI-WC HEME DOMAIN IN COMPLEX WITH TESTOSTERONE 
631, 5lieA, 0.8307, 2.76, 0.299, 379, 368, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH IMIDAZOLE
632, 4nz2A, 0.8307, 3.18, 0.154, 464, 382, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH AN INHIBITOR
633, 4kpbB, 0.8307, 3.25, 0.129, 444, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 R47E MUTANT
634, 2vn0A, 0.8307, 3.22, 0.157, 464, 382, CYP2C8DH COMPLEXED WITH TROGLITAZONE
635, 2nnhB, 0.8307, 3.23, 0.157, 463, 382, CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID
636, 2ferA, 0.8307, 3.01, 0.219, 405, 375, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
637, 1lfkA, 0.8307, 2.86, 0.270, 375, 370, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
638, 2h7sA, 0.8306, 2.98, 0.217, 405, 374, L244A MUTANT OF CYTOCHROME P450CAM
639, 3c6gA, 0.8305, 3.30, 0.140, 464, 385, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D3
640, 2h7sC, 0.8305, 2.98, 0.214, 405, 374, L244A MUTANT OF CYTOCHROME P450CAM
641, 2qbmA, 0.8304, 3.01, 0.219, 405, 375, CRYSTAL STRUCTURE OF THE P450CAM G248T MUTANT IN THE CYANIDE BOUND STATE
642, 1zo4A, 0.8304, 3.25, 0.124, 456, 380, CRYSTAL STRUCTURE OF A328S MUTANT OF THE HEME DOMAIN OF P450BM-3
643, 1uyuA, 0.8304, 3.01, 0.219, 404, 375, XENON COMPLEX OF WILDTYPE P450CAM FROM PSEUDOMONAS PUTIDA
644, 2ij3A, 0.8303, 3.25, 0.118, 453, 380, STRUCTURE OF THE A264H MUTANT OF CYTOCHROME P450 BM3
645, 1og5A, 0.8303, 3.24, 0.151, 461, 383, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
646, 2uwhF, 0.8302, 3.27, 0.126, 458, 380, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
647, 2qboA, 0.8302, 3.00, 0.219, 405, 375, CRYSTAL STRUCTURE OF THE P450CAM G248V MUTANT IN THE CYANIDE BOUND STATE
648, 2nnbA, 0.8302, 3.24, 0.121, 441, 380, THE Q403K MUTNAT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
649, 2j1mB, 0.8302, 3.36, 0.123, 454, 381, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
650, 1phdA, 0.8302, 3.00, 0.216, 405, 375, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE-INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
651, 1og2B, 0.8302, 3.20, 0.154, 461, 382, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
652, 4r21B, 0.8301, 3.10, 0.177, 423, 378, ZEBRA FISH CYTOCHROME P450 17A2 WITH PROGESTERONE
653, 4i8vB, 0.8300, 3.25, 0.130, 472, 385, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
654, 4hgjB, 0.8300, 3.31, 0.124, 451, 380, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT
655, 2hpdA, 0.8300, 3.28, 0.121, 457, 380, CRYSTAL STRUCTURE OF HEMOPROTEIN DOMAIN OF P450BM-3 A PROTOTYPE FOR MICROSOMAL P450 S
656, 1jmeA, 0.8300, 3.25, 0.118, 441, 380, CRYSTAL STRUCTURE OF PHE393HIS CYTOCHROME P450 BM3
657, 5b2vA, 0.8299, 3.30, 0.121, 453, 380, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL-L-TRYPTOPHAN
658, 4egmC, 0.8299, 3.00, 0.207, 393, 372, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
659, 1yqoA, 0.8299, 3.27, 0.118, 441, 380, T268A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
660, 4hgiB, 0.8298, 3.29, 0.121, 453, 380, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET II)
661, 4dnzC, 0.8298, 2.94, 0.208, 393, 371, THE CRYSTAL STRUCTURES OF CYP199A4
662, 2j4sA, 0.8298, 3.26, 0.121, 452, 380, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
663, 1p0vA, 0.8298, 3.26, 0.118, 441, 380, F393A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
664, 1dz6A, 0.8298, 3.02, 0.216, 404, 375, FERROUS P450CAM FROM PSEUDOMONAS PUTIDA
665, 5jquA, 0.8297, 3.29, 0.118, 452, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
666, 2gr6B, 0.8297, 2.99, 0.211, 405, 374, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A)
667, 1gjmA, 0.8297, 3.04, 0.216, 405, 375, COVALENT ATTACHMENT OF AN ELECTROACTIVE SULPHYDRYL REAGENT IN THE ACTIVE SITE OF CYTOCHROME P450CAM
668, 4xrzB, 0.8296, 3.20, 0.155, 458, 381, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
669, 4hghB, 0.8296, 3.31, 0.121, 455, 380, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET I)
670, 2qbnA, 0.8296, 3.01, 0.219, 405, 375, CRYSTAL STRUCTURE OF FERRIC G248V CYTOCHROME P450CAM
671, 2a1nB, 0.8296, 3.02, 0.219, 405, 375, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF D251N CYTOCHROME P450CAM
672, 1yqpA, 0.8296, 3.26, 0.118, 441, 380, T268N MUTANT CYTOCHROME DOMAIN OF FLAVOCYTOCHROME P450 BM3
673, 1p0xA, 0.8296, 3.26, 0.118, 441, 380, F393Y MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
674, 1p0wA, 0.8296, 3.25, 0.118, 441, 380, F393W MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
675, 1j51D, 0.8296, 3.00, 0.214, 405, 374, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
676, 5b2vB, 0.8295, 3.28, 0.126, 453, 380, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL-L-TRYPTOPHAN
677, 2jjpA, 0.8295, 3.20, 0.275, 397, 374, STRUCTURE OF CYTOCHROME P450 ERYK IN COMPLEX WITH INHIBITOR KETOCONAZOLE (KC)
678, 1bu7A, 0.8295, 3.30, 0.121, 455, 380, CRYOGENIC STRUCTURE OF CYTOCHROME P450BM-3 HEME DOMAIN
679, 5ncbA, 0.8294, 2.94, 0.212, 396, 372, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH GUAIACOL. 
680, 2j1mA, 0.8294, 3.32, 0.124, 454, 380, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
681, 1fahA, 0.8294, 3.29, 0.118, 455, 380, STRUCTURE OF CYTOCHROME P450
682, 4nz2B, 0.8293, 3.16, 0.157, 464, 381, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH AN INHIBITOR
683, 4i8vA, 0.8293, 3.28, 0.127, 477, 386, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
684, 4dtyB, 0.8293, 3.30, 0.124, 453, 380, CYTOCHROME P450 BM3H-8C8 MRI SENSOR NO LIGAND
685, 1j51B, 0.8293, 3.00, 0.217, 405, 374, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
686, 5jquH, 0.8292, 3.33, 0.118, 450, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
687, 5dypA, 0.8292, 3.30, 0.124, 440, 380, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3
688, 5b2yA, 0.8292, 3.31, 0.121, 452, 380, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODECANOYL-L-TRYPTOPHAN
689, 4duaB, 0.8292, 3.28, 0.118, 457, 380, CYTOCHROME P450 BM3H-9D7 MRI SENSOR NO LIGAND
690, 3wrlE, 0.8292, 3.03, 0.219, 405, 375, CRYSTAL STRUCTURE OF P450CAM
691, 1p7rA, 0.8292, 3.02, 0.219, 407, 375, CRYSTAL STRUCTURE OF REDUCED CO-EXPOSED COMPLEX OF CYTOCHROME P450CAM WITH (S)-(-)-NICOTINE
692, 5jtdA, 0.8291, 3.31, 0.124, 458, 380, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH DMSO.
693, 2j4sB, 0.8291, 3.21, 0.122, 450, 378, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
694, 1p2yA, 0.8291, 3.02, 0.219, 407, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM IN COMPLEX WITH (S)- (-)-NICOTINE
695, 1gebA, 0.8291, 3.02, 0.213, 405, 375, X-RAY CRYSTAL STRUCTURE AND CATALYTIC PROPERTIES OF THR252ILE MUTANT OF CYTOCHROME P450CAM
696, 4uaxA, 0.8290, 3.00, 0.258, 401, 372, X-RAY CRYSTAL STRUCTURE OF LIGAND FREE CYP142A2 FROM MYCOBACTERIUM SMEGMATIS
697, 5li6A, 0.8289, 2.71, 0.287, 377, 366, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH N-ISOPROPYL-N-((3-(4-METHOXYPHENYL)-124-OXADIAZOL-5-YL) METHYL)-2-(4-NITROPHENYL)ACETAMIDE
698, 5b2yB, 0.8289, 3.28, 0.126, 452, 380, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODECANOYL-L-TRYPTOPHAN
699, 4zfaA, 0.8289, 3.28, 0.124, 460, 380, CYTOCHROME P450 WILD TYPE FROM BM3 WITH BOUND PEG
700, 4egoC, 0.8289, 2.88, 0.208, 393, 370, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
701, 2bmhA, 0.8289, 3.29, 0.121, 455, 380, MODELING PROTEIN-SUBSTRATE INTERACTIONS IN THE HEME DOMAIN OF CYTOCHROME P450BM-3
702, 1mpwB, 0.8289, 3.04, 0.216, 405, 375, MOLECULAR RECOGNITION IN (+)-A-PINENE OXIDATION BY CYTOCHROME P450CAM
703, 4hgjA, 0.8288, 3.31, 0.124, 448, 380, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT
704, 4dufB, 0.8288, 3.30, 0.113, 456, 380, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
705, 4dtwA, 0.8288, 3.29, 0.118, 453, 380, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO SEROTONIN
706, 3tdaC, 0.8288, 3.11, 0.158, 467, 379, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
707, 3benB, 0.8288, 3.32, 0.121, 457, 380, STRUCTURE OF N-(12-IMIDAZOLYL-DODECANOYL)-L-LEUCINE INHIBITOR BOUND TO THE HEME DOMAIN OF CYTOCHROME P450-BM3
708, 3benA, 0.8288, 3.32, 0.121, 454, 380, STRUCTURE OF N-(12-IMIDAZOLYL-DODECANOYL)-L-LEUCINE INHIBITOR BOUND TO THE HEME DOMAIN OF CYTOCHROME P450-BM3
709, 1nr6A, 0.8288, 3.26, 0.146, 462, 383, MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH DICLOFENAC
710, 1n6bA, 0.8288, 3.16, 0.150, 462, 381, MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH A DIMETHYL DERIVATIVE OF SULFAPHENAZOLE
711, 5jqvB, 0.8287, 3.40, 0.126, 453, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
712, 4gqsC, 0.8287, 3.29, 0.156, 462, 384, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
713, 4dtwB, 0.8287, 3.30, 0.124, 453, 380, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO SEROTONIN
714, 3qm4A, 0.8287, 3.27, 0.160, 465, 382, HUMAN CYTOCHROME P450 (CYP) 2D6 - PRINOMASTAT COMPLEX
715, 2nnhA, 0.8287, 3.26, 0.157, 463, 382, CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID
716, 1bvyB, 0.8287, 3.15, 0.122, 438, 376, COMPLEX OF THE HEME AND FMN-BINDING DOMAINS OF THE CYTOCHROME P450(BM-3)
717, 5jtdB, 0.8286, 3.33, 0.121, 458, 380, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH DMSO.
718, 4j14A, 0.8286, 3.36, 0.184, 436, 381, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 CYP46A1 WITH POSACONAZOLE BOUND
719, 4dtzB, 0.8286, 3.30, 0.118, 453, 380, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO DOPAMINE
720, 3kx5A, 0.8286, 3.30, 0.121, 455, 380, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT F261E
721, 5jqvA, 0.8285, 3.31, 0.118, 453, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
722, 4fb2B, 0.8285, 2.89, 0.211, 392, 374, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
723, 4dubB, 0.8284, 3.30, 0.118, 456, 380, CYTOCHROME P450 BM3H-9D7 MRI SENSOR BOUND TO DOPAMINE
724, 4dtzA, 0.8284, 3.30, 0.118, 453, 380, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO DOPAMINE
725, 3tdaA, 0.8284, 3.12, 0.158, 467, 379, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
726, 5li6B, 0.8283, 2.68, 0.288, 376, 365, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH N-ISOPROPYL-N-((3-(4-METHOXYPHENYL)-124-OXADIAZOL-5-YL) METHYL)-2-(4-NITROPHENYL)ACETAMIDE
727, 4egpB, 0.8283, 2.97, 0.208, 393, 371, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 2-NAPHTHOIC ACID
728, 3wrjE, 0.8283, 3.05, 0.219, 405, 375, CRYSTAL STRUCTURE OF P450CAM
729, 2gqxB, 0.8283, 3.02, 0.211, 405, 374, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A) WITH PENTACHLOROBENZENE
730, 1t88B, 0.8283, 3.05, 0.219, 405, 375, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM (C334A)
731, 4fb2C, 0.8282, 2.84, 0.204, 390, 372, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
732, 3wrmF, 0.8282, 3.05, 0.219, 405, 375, CRYSTAL STRUCTURE OF P450CAM
733, 2zujA, 0.8282, 3.04, 0.219, 405, 375, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT(D297L)
734, 2z97A, 0.8282, 3.03, 0.219, 405, 375, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM RECONSTITUTED WITH 7- METHYL-7-DEPROPIONATED HEMIN
735, 6cizB, 0.8281, 3.35, 0.164, 469, 385, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
736, 6cizA, 0.8281, 3.37, 0.163, 468, 386, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
737, 4dtyA, 0.8281, 3.29, 0.118, 453, 380, CYTOCHROME P450 BM3H-8C8 MRI SENSOR NO LIGAND
738, 4do1C, 0.8281, 3.03, 0.207, 393, 372, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
739, 3wrhE, 0.8281, 3.05, 0.219, 405, 375, CRYSTAL STRUCTURE OF P450CAM
740, 1pq2A, 0.8281, 3.20, 0.163, 463, 381, CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROME P450 2C8
741, 5jqvD, 0.8280, 3.32, 0.118, 454, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
742, 2ve3B, 0.8280, 2.89, 0.156, 427, 372, RETINOIC ACID BOUND CYANOBACTERIAL CYP120A1
743, 1yrdA, 0.8280, 3.05, 0.216, 405, 375, X-RAY CRYSTAL STRUCTURE OF PERDEUTERATED CYTOCHROME P450CAM
744, 6chiB, 0.8279, 3.35, 0.164, 468, 385, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
745, 4i8vC, 0.8279, 3.30, 0.130, 468, 385, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
746, 2nnjA, 0.8279, 3.26, 0.157, 463, 382, CYP2C8DH COMPLEXED WITH FELODIPINE
747, 2nniA, 0.8279, 3.28, 0.154, 463, 383, CYP2C8DH COMPLEXED WITH MONTELUKAST
748, 1bvyA, 0.8279, 3.11, 0.122, 439, 376, COMPLEX OF THE HEME AND FMN-BINDING DOMAINS OF THE CYTOCHROME P450(BM-3)
749, 5xw2A, 0.8278, 2.68, 0.267, 375, 363, CRYSTAL STRUCTURE OF THE HYDROXYLASE HMTN IN C 1 2 1 CRYSTAL FORM 
750, 4fiaA, 0.8278, 3.33, 0.182, 426, 380, CRYSTAL STRUCTURE OF HUMAN CYP46A1 P450 WITH BICALUTAMIDE BOUND
751, 3wspA, 0.8278, 3.33, 0.121, 453, 380, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORONONANOYL-L-TRYPTOPHAN
752, 2ij4A, 0.8278, 3.29, 0.127, 451, 379, STRUCTURE OF THE A264K MUTANT OF CYTOCHROME P450 BM3
753, 1dz4A, 0.8278, 3.05, 0.219, 404, 375, FERRIC P450CAM FROM PSEUDOMONAS PUTIDA
754, 6chiA, 0.8277, 3.35, 0.164, 466, 385, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
755, 4egnC, 0.8277, 2.89, 0.208, 393, 370, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
756, 3fwiA, 0.8277, 3.04, 0.211, 405, 375, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND TETRAGONAL CRYSTAL FORM
757, 2zuhA, 0.8277, 3.04, 0.221, 405, 375, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT (D297A)
758, 2z3tB, 0.8277, 2.76, 0.280, 376, 364, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
759, 5xa3D, 0.8276, 3.32, 0.124, 453, 380, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
760, 4kf2A, 0.8276, 3.33, 0.126, 451, 380, STRUCTURE OF THE P4509 BM3 A82F F87V HEME DOMAIN
761, 2zwtA, 0.8276, 3.05, 0.219, 405, 375, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM
762, 5xa3A, 0.8275, 3.33, 0.124, 453, 380, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
763, 5e9zC, 0.8275, 3.33, 0.132, 445, 380, CYTOCHROME P450 BM3 MUTANT M11
764, 3cbdA, 0.8275, 3.34, 0.123, 455, 381, DIRECTED EVOLUTION OF CYTOCHROME P450 BM3 TO OCTANE MONOXYGENASE 139-3
765, 4zfbA, 0.8274, 3.39, 0.123, 460, 381, CYTOCHROME P450 PENTAMUTANT FROM BM3 BOUND TO PALMITIC ACID
766, 3zbyC, 0.8274, 3.09, 0.257, 402, 373, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
767, 2qblA, 0.8274, 3.06, 0.219, 405, 375, CRYSTAL STRUCTURE OF FERRIC G248T CYTOCHROME P450CAM
768, 4nkwA, 0.8273, 3.38, 0.161, 464, 385, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
769, 4ejgG, 0.8273, 3.23, 0.173, 463, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
770, 3zbyF, 0.8273, 3.09, 0.257, 402, 373, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
771, 3zbyB, 0.8273, 3.09, 0.257, 404, 373, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
772, 3zbyA, 0.8273, 3.09, 0.260, 402, 373, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
773, 2p85B, 0.8273, 3.16, 0.152, 464, 381, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
774, 3zbyD, 0.8272, 3.09, 0.257, 402, 373, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
775, 3wspB, 0.8272, 3.33, 0.121, 453, 380, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORONONANOYL-L-TRYPTOPHAN
776, 2pg5C, 0.8272, 3.17, 0.160, 463, 381, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
777, 1z11C, 0.8272, 3.17, 0.160, 464, 381, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
778, 5veuA, 0.8271, 3.30, 0.141, 462, 382, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
779, 4i8vD, 0.8271, 3.26, 0.125, 467, 383, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
780, 4ducB, 0.8271, 3.31, 0.118, 456, 380, CYTOCHROME P450 BM3H-2G9 MRI SENSOR NO LIGAND
781, 3zbyE, 0.8271, 3.06, 0.260, 402, 373, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
782, 3fwjA, 0.8271, 3.06, 0.213, 405, 375, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND ORTHOROMBIC CRYSTAL FORM
783, 3fwgA, 0.8271, 3.06, 0.216, 404, 375, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM ARG365LEU GLU366GLN MONOCLINIC CRYSTAL FORM
784, 3cbdB, 0.8271, 3.38, 0.126, 455, 381, DIRECTED EVOLUTION OF CYTOCHROME P450 BM3 TO OCTANE MONOXYGENASE 139-3
785, 2ij4B, 0.8271, 3.33, 0.121, 455, 380, STRUCTURE OF THE A264K MUTANT OF CYTOCHROME P450 BM3
786, 2fdvC, 0.8271, 3.18, 0.160, 464, 381, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
787, 5b2uB, 0.8270, 3.33, 0.124, 453, 380, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL -L-TRYPTOPHAN
788, 4zf8A, 0.8270, 3.32, 0.129, 460, 380, CYTOCHROME P450 PENTAMUTANT FROM BM3 WITH BOUND METYRAPONE
789, 4g3rB, 0.8270, 3.06, 0.219, 405, 375, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CAM
790, 4egoB, 0.8270, 2.97, 0.208, 393, 371, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
791, 4c9pB, 0.8270, 3.15, 0.181, 407, 375, STRUCTURE OF CAMPHOR BOUND T260A MUTANT OF CYP101D1
792, 3fwfB, 0.8270, 3.05, 0.211, 405, 375, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND MONOCLINIC CRYSTAL FORM
793, 2m56A, 0.8270, 3.06, 0.219, 404, 375, THE STRUCTURE OF THE COMPLEX OF CYTOCHROME P450CAM AND ITS ELECTRON DONOR PUTIDAREDOXIN DETERMINED BY PARAMAGNETIC NMR SPECTROSCOPY
794, 1smiB, 0.8270, 3.32, 0.121, 455, 380, A SINGLE MUTATION OF P450 BM3 INDUCES THE CONFORMATIONAL REARRANGEMENT SEEN UPON SUBSTRATE-BINDING IN WILD-TYPE ENZYME
795, 1c8jB, 0.8270, 3.06, 0.216, 405, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F)
796, 5uysB, 0.8269, 3.37, 0.164, 470, 385, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
797, 4ejhE, 0.8269, 3.16, 0.152, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
798, 2pg7C, 0.8269, 3.15, 0.163, 464, 380, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
799, 2feuA, 0.8269, 3.04, 0.219, 404, 374, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
800, 2fdyC, 0.8269, 3.18, 0.160, 464, 381, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
801, 5vc0A, 0.8268, 3.35, 0.159, 463, 383, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO RITONAVIR
802, 5jquG, 0.8268, 3.40, 0.118, 451, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
803, 5jq2A, 0.8268, 3.33, 0.124, 457, 380, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH N-PALMITOYLGLYCINE
804, 4l4cB, 0.8268, 3.06, 0.219, 405, 375, STRUCTURE OF L358P/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
805, 3kx4A, 0.8268, 3.25, 0.124, 453, 379, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT I401E
806, 3el3B, 0.8268, 2.77, 0.190, 417, 369, DISTINCT MONOOXYGENASE AND FARNESENE SYNTHASE ACTIVE SITES IN CYTOCHROME P450 170A1
807, 2fduC, 0.8268, 3.21, 0.160, 464, 382, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
808, 6chiC, 0.8267, 3.51, 0.160, 476, 387, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
809, 5xhjB, 0.8267, 3.34, 0.124, 453, 380, CRYSTAL STRUCTURE OF P450BM3 WITH 5-CYCLOHEXYLVALEROYL-L-TRYPTOPHAN
810, 4nkwB, 0.8267, 3.38, 0.161, 464, 385, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
811, 4gqsB, 0.8267, 3.33, 0.154, 456, 383, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
812, 4egoA, 0.8267, 2.97, 0.208, 393, 371, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
813, 3qm4B, 0.8267, 3.28, 0.155, 457, 381, HUMAN CYTOCHROME P450 (CYP) 2D6 - PRINOMASTAT COMPLEX
814, 5xa3C, 0.8266, 3.36, 0.124, 453, 380, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
815, 5b2uA, 0.8266, 3.34, 0.124, 453, 380, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL -L-TRYPTOPHAN
816, 4r21A, 0.8266, 3.06, 0.176, 422, 375, ZEBRA FISH CYTOCHROME P450 17A2 WITH PROGESTERONE
817, 2pg6C, 0.8266, 3.19, 0.160, 464, 381, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
818, 2fdwC, 0.8266, 3.21, 0.160, 464, 382, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
819, 1z10C, 0.8266, 3.21, 0.160, 464, 382, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
820, 6cizC, 0.8265, 3.51, 0.160, 477, 387, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
821, 5b2xB, 0.8265, 3.34, 0.126, 453, 380, CRYSTAL STRUCTURE OF P450BM3 MUTANT WITH N-PERFLUOROHEPTANOYL-L- TRYPTOPHAN
822, 4zf6A, 0.8265, 3.34, 0.129, 460, 380, CYTOCHROME P450 PENTAMUTANT FROM BM3 WITH BOUND PEG
823, 4h24A, 0.8265, 3.33, 0.132, 457, 380, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
824, 2zwuA, 0.8265, 3.06, 0.219, 405, 375, CRYSTAL STRUCTURE OF CAMPHOR SOAKED FERRIC CYTOCHROME P450CAM
825, 2ve3A, 0.8265, 3.04, 0.157, 435, 375, RETINOIC ACID BOUND CYANOBACTERIAL CYP120A1
826, 5xa3B, 0.8264, 3.36, 0.124, 453, 380, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
827, 5dypC, 0.8264, 3.33, 0.124, 450, 380, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3
828, 4nkvA, 0.8264, 3.37, 0.161, 466, 385, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
829, 2zuiA, 0.8264, 3.06, 0.216, 405, 375, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT (D297N)
830, 2uwhC, 0.8264, 3.39, 0.121, 458, 381, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
831, 4c9lB, 0.8263, 3.14, 0.184, 407, 375, STRUCTURE OF CYANIDE AND CAMPHOR BOUND WILD TYPE CYP101D1
832, 3mdvA, 0.8263, 3.19, 0.186, 424, 377, CLOTRIMAZOLE COMPLEX OF CYTOCHROME P450 46A1
833, 5tftA, 0.8262, 3.19, 0.163, 467, 380, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
834, 5e9zD, 0.8262, 3.31, 0.129, 444, 379, CYTOCHROME P450 BM3 MUTANT M11
835, 5e9zA, 0.8262, 3.34, 0.132, 452, 380, CYTOCHROME P450 BM3 MUTANT M11
836, 3oftC, 0.8262, 2.81, 0.231, 390, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
837, 3nplB, 0.8262, 3.33, 0.129, 456, 380, STRUCTURE OF RU(BPY)2(A-PHEN)(K97C) P450 BM3 HEME DOMAIN A RUTHENIUM MODIFIED P450 BM3 MUTANT
838, 3mdvB, 0.8262, 3.19, 0.186, 424, 377, CLOTRIMAZOLE COMPLEX OF CYTOCHROME P450 46A1
839, 3kx3B, 0.8262, 3.41, 0.123, 456, 381, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT L86E
840, 2frzB, 0.8262, 3.05, 0.217, 405, 374, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A)
841, 2fe6A, 0.8262, 3.06, 0.216, 405, 375, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
842, 1yrcA, 0.8262, 3.07, 0.219, 405, 375, X-RAY CRYSTAL STRUCTURE OF HYDROGENATED CYTOCHROME P450CAM
843, 6cirC, 0.8261, 3.42, 0.158, 472, 385, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
844, 6chiD, 0.8261, 3.50, 0.161, 467, 386, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
845, 5uysA, 0.8261, 3.41, 0.163, 471, 386, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
846, 4xrzA, 0.8261, 3.27, 0.155, 457, 381, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
847, 4nkyA, 0.8261, 3.34, 0.167, 462, 384, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
848, 3ebsC, 0.8261, 3.20, 0.165, 464, 381, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
849, 2zaxA, 0.8261, 3.07, 0.219, 405, 375, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM
850, 2fduD, 0.8261, 3.19, 0.163, 464, 381, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
851, 1jpzB, 0.8261, 3.41, 0.123, 458, 381, CRYSTAL STRUCTURE OF A COMPLEX OF THE HEME DOMAIN OF P450BM- 3 WITH N-PALMITOYLGLYCINE
852, 6cirB, 0.8260, 3.33, 0.169, 466, 384, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
853, 5x23A, 0.8260, 3.30, 0.151, 463, 383, CRYSTAL STRUCTURE OF CYP2C9 GENETIC VARIANT A477T (*30) IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
854, 5tftB, 0.8260, 3.12, 0.164, 460, 379, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
855, 5irqC, 0.8260, 3.41, 0.158, 472, 385, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
856, 4nkyB, 0.8260, 3.33, 0.167, 464, 384, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
857, 4nkxB, 0.8260, 3.34, 0.167, 468, 384, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
858, 4h24D, 0.8260, 3.41, 0.139, 455, 381, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
859, 4ejjA, 0.8260, 3.15, 0.168, 465, 380, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
860, 4ejhC, 0.8260, 3.17, 0.152, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
861, 3tbgC, 0.8260, 3.21, 0.163, 467, 380, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
862, 3nplA, 0.8260, 3.34, 0.124, 456, 380, STRUCTURE OF RU(BPY)2(A-PHEN)(K97C) P450 BM3 HEME DOMAIN A RUTHENIUM MODIFIED P450 BM3 MUTANT
863, 3el3A, 0.8260, 2.76, 0.190, 417, 369, DISTINCT MONOOXYGENASE AND FARNESENE SYNTHASE ACTIVE SITES IN CYTOCHROME P450 170A1
864, 1z11D, 0.8260, 3.19, 0.163, 464, 381, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
865, 5veuD, 0.8259, 3.34, 0.154, 459, 382, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
866, 5jqvC, 0.8259, 3.32, 0.127, 452, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
867, 5e78B, 0.8259, 3.31, 0.124, 454, 380, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN VARIANT COMPLEXED WITH CO(III)SEP
868, 4nkvC, 0.8259, 3.41, 0.156, 471, 385, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
869, 4kpaA, 0.8259, 3.36, 0.126, 461, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 IN COMPLEX WITH N- PALMITOYLGLYCINE (NPG)
870, 4ejgE, 0.8259, 3.17, 0.155, 465, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
871, 3tbgA, 0.8259, 3.21, 0.161, 467, 380, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
872, 3rukB, 0.8259, 3.37, 0.164, 465, 385, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
873, 3rukA, 0.8259, 3.33, 0.169, 464, 384, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
874, 2uwhD, 0.8259, 3.46, 0.123, 458, 382, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
875, 2pg5D, 0.8259, 3.19, 0.163, 464, 381, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
876, 1z10D, 0.8259, 3.19, 0.163, 464, 381, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
877, 6cirA, 0.8258, 3.38, 0.164, 466, 385, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
878, 5irqB, 0.8258, 3.40, 0.163, 467, 386, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
879, 4dudB, 0.8258, 3.34, 0.118, 456, 380, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR NO LIGAND
880, 3mdtB, 0.8258, 3.25, 0.185, 424, 378, VORICONAZOLE COMPLEX OF CYTOCHROME P450 46A1
881, 2uwhE, 0.8258, 3.40, 0.126, 458, 381, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
882, 6cizD, 0.8257, 3.51, 0.161, 468, 386, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
883, 5veuC, 0.8257, 3.39, 0.159, 469, 383, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
884, 5jquD, 0.8257, 3.32, 0.116, 454, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
885, 5jquC, 0.8257, 3.35, 0.118, 453, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
886, 5irqA, 0.8257, 3.39, 0.164, 466, 385, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
887, 4h24C, 0.8257, 3.34, 0.139, 456, 380, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
888, 4dnjA, 0.8257, 3.03, 0.223, 399, 372, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A2
889, 4c9oB, 0.8257, 3.17, 0.184, 407, 375, STRUCTURE OF CYANIDE AND CAMPHOR BOUND D259N MUTANT OF CYP101D1
890, 4c9kB, 0.8257, 3.16, 0.184, 407, 375, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND WILD TYPE CYP101D1
891, 3t3rA, 0.8257, 3.16, 0.166, 463, 380, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
892, 3m4vA, 0.8257, 3.34, 0.121, 451, 380, CRYSTAL STRUCTURE OF THE A330P MUTANT OF CYTOCHROME P450 BM3
893, 3ekfB, 0.8257, 3.37, 0.124, 452, 380, CRYSTAL STRUCTURE OF THE A264Q HEME DOMAIN OF CYTOCHROME P450 BM3
894, 3ekbA, 0.8257, 3.32, 0.119, 442, 378, CRYSTAL STRUCTURE OF THE A264C MUTANT HEME DOMAIN OF CYTOCHROME P450 BM3
895, 5yhjB, 0.8256, 3.19, 0.149, 411, 376, CYTOCHROME P450EX ALPHA (CYP152N1) WILD-TYPE WITH MYRISTIC ACID
896, 5uysC, 0.8256, 3.53, 0.160, 473, 387, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
897, 5e9zB, 0.8256, 3.42, 0.131, 451, 381, CYTOCHROME P450 BM3 MUTANT M11
898, 4nkxA, 0.8256, 3.34, 0.167, 466, 384, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
899, 4nkvB, 0.8256, 3.41, 0.161, 467, 386, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
900, 4enhA, 0.8256, 3.20, 0.183, 426, 377, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 CYP46A1 WITH FLUVOXAMINE BOUND
901, 4ejgA, 0.8256, 3.19, 0.155, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
902, 4c9nA, 0.8256, 3.16, 0.184, 408, 375, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND D259N MUTANT OF CYP101D1
903, 4c9mB, 0.8256, 3.17, 0.184, 407, 375, STRUCTURE OF SUBSTRATE FREE GLYCEROL BOUND WILD TYPE CYP101D1
904, 3ofuF, 0.8256, 2.83, 0.239, 390, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
905, 3ofuE, 0.8256, 2.87, 0.228, 390, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
906, 2uwhA, 0.8256, 3.41, 0.121, 458, 381, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
907, 1zo9A, 0.8256, 3.36, 0.124, 458, 380, CRYSTAL STRUCTURE OF THE WILD TYPE HEME DOMAIN OF P450BM-3 WITH N- PALMITOYLMETHIONINE
908, 1smjA, 0.8256, 3.40, 0.118, 455, 381, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
909, 5veuH, 0.8255, 3.33, 0.154, 459, 382, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
910, 5ucwA, 0.8255, 3.38, 0.121, 453, 380, CYTOCHROME P411 P-4 A82L A78V F263L AMINATION CATALYST
911, 5jqvF, 0.8255, 3.37, 0.124, 455, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
912, 5irvB, 0.8255, 3.41, 0.164, 471, 385, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
913, 4wnvA, 0.8255, 3.18, 0.158, 464, 379, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
914, 4ejiA, 0.8255, 3.19, 0.154, 464, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH TWO MOLECULES OF 4- (METHYLNITROSAMINO)-1-(3-PURIDYL)-1-BUTANONE
915, 4ejgC, 0.8255, 3.18, 0.152, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
916, 4egnB, 0.8255, 2.99, 0.208, 393, 371, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
917, 4du2B, 0.8255, 3.44, 0.121, 444, 381, CYTOCHROME P450 BM3H-B7 MRI SENSOR BOUND TO DOPAMINE
918, 4c9pA, 0.8255, 3.16, 0.181, 408, 375, STRUCTURE OF CAMPHOR BOUND T260A MUTANT OF CYP101D1
919, 4c9oA, 0.8255, 3.17, 0.184, 408, 375, STRUCTURE OF CYANIDE AND CAMPHOR BOUND D259N MUTANT OF CYP101D1
920, 3t3qD, 0.8255, 3.19, 0.165, 463, 381, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
921, 2fdwD, 0.8255, 3.20, 0.163, 464, 381, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
922, 5veuB, 0.8254, 3.33, 0.152, 458, 382, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
923, 5e0eA, 0.8254, 3.37, 0.183, 463, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B37 FROM DESERT WOODRAT IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
924, 4wnwA, 0.8254, 3.24, 0.161, 461, 380, HUMAN CYTOCHROME P450 2D6 THIORIDAZINE COMPLEX
925, 4kpbA, 0.8254, 3.26, 0.124, 440, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 R47E MUTANT
926, 4kf2B, 0.8254, 3.35, 0.126, 448, 380, STRUCTURE OF THE P4509 BM3 A82F F87V HEME DOMAIN
927, 4dnzB, 0.8254, 3.00, 0.208, 393, 371, THE CRYSTAL STRUCTURES OF CYP199A4
928, 3mdrA, 0.8254, 3.31, 0.185, 427, 379, TRANYLCYPROMINE COMPLEX OF CYTOCHROME P450 46A1
929, 2ij2B, 0.8254, 3.25, 0.122, 448, 378, ATOMIC STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME P450- BM3
930, 1fagD, 0.8254, 3.42, 0.121, 455, 381, STRUCTURE OF CYTOCHROME P450
931, 4gqsA, 0.8253, 3.38, 0.159, 464, 384, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
932, 4do1A, 0.8253, 2.99, 0.208, 393, 371, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
933, 3kx3A, 0.8253, 3.42, 0.123, 454, 381, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT L86E
934, 2pg6D, 0.8253, 3.20, 0.163, 464, 381, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
935, 1zo9B, 0.8253, 3.36, 0.124, 458, 380, CRYSTAL STRUCTURE OF THE WILD TYPE HEME DOMAIN OF P450BM-3 WITH N- PALMITOYLMETHIONINE
936, 1smjD, 0.8253, 3.40, 0.118, 454, 381, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
937, 1pq2B, 0.8253, 3.26, 0.157, 463, 381, CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROME P450 2C8
938, 1fagA, 0.8253, 3.42, 0.121, 455, 381, STRUCTURE OF CYTOCHROME P450
939, 5jqvE, 0.8252, 3.35, 0.121, 451, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
940, 5dyzC, 0.8252, 3.33, 0.126, 453, 380, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3 IN COMPLEX WITH N-PALMITOYLGLYCINE
941, 5b2wB, 0.8252, 3.35, 0.126, 452, 380, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODODECANOYL-L-TRYPTOPHAN
942, 4nkwD, 0.8252, 3.45, 0.156, 467, 385, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
943, 4egmB, 0.8252, 2.99, 0.208, 394, 371, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
944, 4do1B, 0.8252, 2.93, 0.208, 393, 370, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
945, 4c9nB, 0.8252, 3.17, 0.184, 407, 375, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND D259N MUTANT OF CYP101D1
946, 3swzA, 0.8252, 3.34, 0.169, 471, 384, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
947, 3rukD, 0.8252, 3.38, 0.159, 473, 384, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
948, 3mdrB, 0.8252, 3.31, 0.185, 425, 379, TRANYLCYPROMINE COMPLEX OF CYTOCHROME P450 46A1
949, 3lxhB, 0.8252, 3.18, 0.184, 405, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D1
950, 2zawA, 0.8252, 3.08, 0.219, 405, 375, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM RECONSTITUTED WITH 6- METHYL-6-DEPROPIONATED HEMIN
951, 1jpzA, 0.8252, 3.36, 0.124, 456, 380, CRYSTAL STRUCTURE OF A COMPLEX OF THE HEME DOMAIN OF P450BM- 3 WITH N-PALMITOYLGLYCINE
952, 5xhjA, 0.8251, 3.36, 0.124, 453, 380, CRYSTAL STRUCTURE OF P450BM3 WITH 5-CYCLOHEXYLVALEROYL-L-TRYPTOPHAN
953, 4kewA, 0.8251, 3.33, 0.124, 450, 379, STRUCTURE OF THE A82F BM3 HEME DOMAIN IN COMPLEX WITH OMEPRAZOLE
954, 4egnA, 0.8251, 2.93, 0.208, 393, 370, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
955, 4dufC, 0.8251, 3.36, 0.118, 456, 380, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
956, 3swzB, 0.8251, 3.39, 0.164, 465, 385, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
957, 5kdyA, 0.8250, 3.05, 0.205, 393, 371, THE CRYSTAL STRUCTURE OF THE D251N MUTANT OF CYP199A4 IN COMPLEX WITH 4-METHOXYBENZOATE
958, 5irvA, 0.8250, 3.41, 0.164, 471, 385, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
959, 4xrzD, 0.8250, 3.23, 0.164, 455, 379, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
960, 4ruiE, 0.8250, 3.20, 0.165, 465, 381, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
961, 3lxiB, 0.8250, 3.18, 0.184, 407, 375, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D1
962, 2uwhB, 0.8250, 3.43, 0.121, 458, 381, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
963, 5veuJ, 0.8249, 3.34, 0.152, 458, 382, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
964, 4nkxC, 0.8249, 3.45, 0.156, 469, 385, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
965, 4ejhD, 0.8249, 3.19, 0.152, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
966, 4ejhB, 0.8249, 3.19, 0.152, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
967, 4dueA, 0.8249, 3.38, 0.118, 453, 380, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR BOUND TO SEROTONIN
968, 1fagC, 0.8249, 3.43, 0.123, 455, 381, STRUCTURE OF CYTOCHROME P450
969, 5veuF, 0.8248, 3.33, 0.152, 456, 382, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
970, 5irvC, 0.8248, 3.42, 0.161, 475, 384, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
971, 5a5jA, 0.8248, 3.39, 0.154, 455, 383, CYTOCHROME 2C9 P450 INHIBITOR COMPLEX
972, 4ejhA, 0.8248, 3.18, 0.147, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
973, 4egmA, 0.8248, 3.00, 0.208, 393, 371, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
974, 4e2pA, 0.8248, 2.53, 0.264, 370, 360, CRYSTAL STRUCTURE OF A POST-TAILORING HYDROXYLASE (HMTN) INVOLVED IN THE HIMASTATIN BIOSYNTHESIS
975, 4dnzA, 0.8248, 3.00, 0.208, 393, 371, THE CRYSTAL STRUCTURES OF CYP199A4
976, 4c9lA, 0.8248, 3.16, 0.184, 408, 375, STRUCTURE OF CYANIDE AND CAMPHOR BOUND WILD TYPE CYP101D1
977, 3t3sC, 0.8248, 3.16, 0.155, 464, 380, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
978, 1zoaB, 0.8248, 3.37, 0.124, 457, 380, CRYSTAL STRUCTURE OF A328V MUTANT OF THE HEME DOMAIN OF P450BM-3 WITH N-PALMITOYLGLYCINE
979, 1r9oA, 0.8248, 3.37, 0.149, 455, 383, CRYSTAL STRUCTURE OF P4502C9 WITH FLURBIPROFEN BOUND
980, 1fagB, 0.8248, 3.42, 0.121, 455, 381, STRUCTURE OF CYTOCHROME P450
981, 4h23A, 0.8247, 3.38, 0.126, 454, 380, CYTOCHROME P411BM3-CIS CYCLOPROPANATION CATALYST
982, 4dueB, 0.8247, 3.39, 0.118, 450, 380, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR BOUND TO SEROTONIN
983, 4du2A, 0.8247, 3.45, 0.126, 443, 381, CYTOCHROME P450 BM3H-B7 MRI SENSOR BOUND TO DOPAMINE
984, 5jquF, 0.8246, 3.39, 0.123, 455, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
985, 3swzC, 0.8246, 3.47, 0.161, 470, 386, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
986, 3lxhA, 0.8246, 3.18, 0.184, 408, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D1
987, 3ebsD, 0.8246, 3.17, 0.166, 464, 380, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
988, 1smjB, 0.8246, 3.35, 0.118, 455, 380, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
989, 5veuG, 0.8245, 3.34, 0.152, 455, 382, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
990, 5jqvH, 0.8245, 3.33, 0.121, 450, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
991, 5b2wA, 0.8245, 3.37, 0.124, 452, 380, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODODECANOYL-L-TRYPTOPHAN
992, 4xrzC, 0.8245, 3.22, 0.164, 455, 379, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
993, 4ruiB, 0.8245, 3.17, 0.168, 465, 380, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
994, 4dnzD, 0.8245, 3.01, 0.208, 393, 371, THE CRYSTAL STRUCTURES OF CYP199A4
995, 3mdmA, 0.8245, 3.37, 0.184, 435, 380, THIOPERAMIDE COMPLEX OF CYTOCHROME P450 46A1
996, 2pg5B, 0.8245, 3.19, 0.166, 464, 380, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
997, 2fdvD, 0.8245, 3.21, 0.163, 464, 381, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
998, 1zoaA, 0.8245, 3.37, 0.124, 457, 380, CRYSTAL STRUCTURE OF A328V MUTANT OF THE HEME DOMAIN OF P450BM-3 WITH N-PALMITOYLGLYCINE
999, 4o4pB, 0.8244, 3.39, 0.124, 446, 380, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH S-OMEPRAZOL
1000, 2ve4A, 0.8244, 3.11, 0.160, 431, 375, SUBSTRATE FREE CYANOBACTERIAL CYP120A1
1001, 2pg7D, 0.8244, 3.21, 0.168, 464, 381, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
1002, 5uysD, 0.8243, 3.45, 0.158, 473, 385, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
1003, 5kyoB, 0.8243, 2.99, 0.199, 393, 376, CRYSTAL STRUCTURE OF CYP101J2
1004, 4nkzA, 0.8243, 3.41, 0.161, 463, 385, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
1005, 4egpA, 0.8243, 2.94, 0.208, 393, 370, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 2-NAPHTHOIC ACID
1006, 4c9kA, 0.8243, 3.17, 0.184, 408, 375, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND WILD TYPE CYP101D1
1007, 2v0mC, 0.8243, 3.37, 0.157, 465, 382, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
1008, 2q9fA, 0.8243, 3.23, 0.177, 433, 378, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 46A1 IN COMPLEX WITH CHOLESTEROL-3-SULPHATE
1009, 6cirD, 0.8242, 3.44, 0.158, 471, 385, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
1010, 5xxiA, 0.8242, 3.32, 0.157, 463, 383, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
1011, 5x24A, 0.8242, 3.24, 0.160, 463, 382, CRYSTAL STRUCTURE OF CYP2C9 GENETIC VARIANT I359L (*3) IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
1012, 5u6tA, 0.8242, 3.05, 0.202, 393, 371, THE CRYSTAL STRUCTURE OF 4-ETHOXYBENZOATE-BOUND CYP199A4 
1013, 5jqvG, 0.8242, 3.38, 0.121, 451, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
1014, 4nkzB, 0.8242, 3.29, 0.167, 461, 383, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
1015, 4ejjD, 0.8242, 3.17, 0.163, 464, 380, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
1016, 3t3sB, 0.8242, 3.19, 0.152, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1017, 5yhjA, 0.8241, 3.16, 0.149, 406, 375, CYTOCHROME P450EX ALPHA (CYP152N1) WILD-TYPE WITH MYRISTIC ACID
1018, 4ruiD, 0.8241, 3.22, 0.168, 465, 381, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
1019, 4keyA, 0.8241, 3.35, 0.127, 450, 379, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH OMEPRAZOLE
1020, 4ejjB, 0.8241, 3.22, 0.165, 464, 381, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
1021, 3t3qA, 0.8241, 3.21, 0.165, 463, 381, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
1022, 3m4vB, 0.8241, 3.30, 0.121, 438, 379, CRYSTAL STRUCTURE OF THE A330P MUTANT OF CYTOCHROME P450 BM3
1023, 2q9gA, 0.8241, 3.32, 0.185, 422, 378, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 46A1
1024, 2fduB, 0.8241, 3.20, 0.163, 463, 380, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1025, 1smjC, 0.8241, 3.36, 0.118, 455, 380, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
1026, 5l94B, 0.8240, 2.34, 0.281, 360, 356, THE 2.25 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH TESTOSTERONE
1027, 4k9wC, 0.8240, 3.33, 0.160, 458, 381, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1028, 4c9mA, 0.8240, 3.19, 0.184, 408, 375, STRUCTURE OF SUBSTRATE FREE GLYCEROL BOUND WILD TYPE CYP101D1
1029, 3t3rC, 0.8240, 3.22, 0.163, 463, 381, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
1030, 2pg6B, 0.8240, 3.20, 0.163, 464, 380, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
1031, 4ruiF, 0.8239, 3.22, 0.165, 465, 381, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
1032, 3t3sD, 0.8239, 3.21, 0.152, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1033, 3t3qC, 0.8239, 3.19, 0.166, 463, 380, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
1034, 2fdwB, 0.8239, 3.21, 0.161, 465, 380, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1035, 2fdvB, 0.8239, 3.20, 0.166, 465, 380, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
1036, 5veuI, 0.8238, 3.41, 0.151, 464, 383, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1037, 5u6wA, 0.8238, 3.06, 0.202, 393, 371, THE CRYSTAL STRUCTURE OF 4-METHYLAMINOBENZOATE-BOUND CYP199A4 
1038, 4ruiA, 0.8238, 3.22, 0.163, 464, 381, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
1039, 4nkyC, 0.8238, 3.40, 0.156, 467, 384, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
1040, 4ejgB, 0.8238, 3.21, 0.152, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1041, 3tdaD, 0.8238, 3.22, 0.167, 456, 378, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
1042, 5jquE, 0.8237, 3.36, 0.119, 451, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
1043, 4nkvD, 0.8237, 3.42, 0.156, 466, 384, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
1044, 4egoD, 0.8237, 2.95, 0.208, 393, 370, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
1045, 5irvD, 0.8236, 3.45, 0.161, 472, 385, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
1046, 4nkwC, 0.8236, 3.47, 0.156, 467, 385, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
1047, 4k9wA, 0.8236, 3.37, 0.160, 458, 382, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1048, 4i4gA, 0.8236, 3.31, 0.157, 459, 381, CRYSTAL STRUCTURE OF CYP3A4 LIGATED TO OXAZOLE-SUBSTITUTED DESOXYRITONAVIR
1049, 3t3qB, 0.8236, 3.20, 0.163, 463, 380, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
1050, 3lxiA, 0.8236, 3.19, 0.184, 408, 375, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D1
1051, 1z10B, 0.8236, 3.24, 0.165, 465, 381, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
1052, 5u6uA, 0.8235, 3.06, 0.205, 393, 371, THE CRYSTAL STRUCTURE OF 4-ETHYLTHIOBENZOATE-BOUND CYP199A4 
1053, 4wntA, 0.8235, 3.34, 0.157, 457, 381, HUMAN CYTOCHROME P450 2D6 AJMALICINE COMPLEX
1054, 4k9wD, 0.8235, 3.35, 0.160, 458, 381, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1055, 4h23B, 0.8235, 3.35, 0.132, 448, 379, CYTOCHROME P411BM3-CIS CYCLOPROPANATION CATALYST
1056, 4ejjC, 0.8235, 3.23, 0.168, 464, 381, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
1057, 2pg7B, 0.8235, 3.21, 0.166, 464, 380, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
1058, 2fdyD, 0.8235, 3.17, 0.161, 464, 380, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
1059, 3pm0A, 0.8234, 3.18, 0.116, 459, 380, STRUCTURAL CHARACTERIZATION OF THE COMPLEX BETWEEN ALPHA- NAPHTHOFLAVONE AND HUMAN CYTOCHROME P450 1B1 (CYP1B1)
1060, 1z11B, 0.8234, 3.25, 0.163, 464, 381, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
1061, 5kdbA, 0.8233, 3.06, 0.202, 393, 371, THE CRYSTAL STRUCTURE OF 4-ISOPROPYLBENZOATE-BOUND CYP199A4
1062, 5irqD, 0.8233, 3.55, 0.161, 465, 386, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
1063, 4nkyD, 0.8233, 3.43, 0.156, 465, 384, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
1064, 3tdaB, 0.8233, 3.15, 0.167, 456, 377, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
1065, 3mdtA, 0.8233, 3.28, 0.183, 424, 378, VORICONAZOLE COMPLEX OF CYTOCHROME P450 46A1
1066, 2x7yB, 0.8233, 3.33, 0.132, 439, 378, P450 BM3 F87A IN COMPLEX WITH DMSO
1067, 2fduA, 0.8233, 3.21, 0.163, 465, 380, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1068, 4ejgD, 0.8232, 3.20, 0.150, 465, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1069, 3tmzA, 0.8232, 3.34, 0.158, 463, 380, CRYSTAL STRUCTURE OF P450 2B4(H226Y) IN COMPLEX WITH AMLODIPINE
1070, 3t3sA, 0.8232, 3.22, 0.152, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1071, 1z11A, 0.8232, 3.21, 0.163, 467, 380, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
1072, 4ruiC, 0.8229, 3.23, 0.163, 464, 381, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
1073, 4keyB, 0.8229, 3.28, 0.127, 442, 377, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH OMEPRAZOLE
1074, 4ejhH, 0.8229, 3.24, 0.169, 459, 379, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
1075, 4ejhF, 0.8229, 3.22, 0.152, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
1076, 4egmD, 0.8229, 3.01, 0.208, 393, 371, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
1077, 4do1D, 0.8229, 2.96, 0.208, 393, 370, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
1078, 3swzD, 0.8229, 3.49, 0.164, 466, 385, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
1079, 3fwfA, 0.8229, 3.12, 0.211, 404, 375, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND MONOCLINIC CRYSTAL FORM
1080, 3ebsB, 0.8229, 3.25, 0.165, 466, 381, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
1081, 2pg5A, 0.8229, 3.21, 0.166, 464, 380, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
1082, 5t6qA, 0.8228, 3.35, 0.136, 472, 383, STRUCTURE OF CYTOCHROME P450 4B1 (CYP4B1) COMPLEXED WITH OCTANE: AN N- ALKANE AND FATTY ACID OMEGA-HYDROXYLASE WITH A COVALENTLY BOUND HEME
1083, 5dyzA, 0.8228, 3.37, 0.124, 445, 380, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3 IN COMPLEX WITH N-PALMITOYLGLYCINE
1084, 2p85E, 0.8228, 3.23, 0.152, 464, 381, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1085, 2fdwA, 0.8228, 3.21, 0.166, 465, 380, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1086, 5kt1A, 0.8227, 3.07, 0.202, 393, 371, THE CRYSTAL STRUCTURE OF 4-METHYLTHIOBENZOATE-BOUND CYP199A4
1087, 4kewB, 0.8227, 3.30, 0.125, 443, 377, STRUCTURE OF THE A82F BM3 HEME DOMAIN IN COMPLEX WITH OMEPRAZOLE
1088, 2fdvA, 0.8227, 3.22, 0.163, 465, 380, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
1089, 5veuK, 0.8226, 3.36, 0.155, 458, 381, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1090, 5kyoE, 0.8226, 3.05, 0.199, 390, 377, CRYSTAL STRUCTURE OF CYP101J2
1091, 4nkzC, 0.8226, 3.42, 0.156, 464, 384, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
1092, 4nkxD, 0.8226, 3.46, 0.156, 468, 384, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
1093, 4egnD, 0.8226, 2.96, 0.208, 393, 370, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
1094, 3t3sG, 0.8226, 3.23, 0.160, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1095, 2ve4B, 0.8226, 3.14, 0.157, 432, 375, SUBSTRATE FREE CYANOBACTERIAL CYP120A1
1096, 2pg7A, 0.8226, 3.22, 0.163, 464, 380, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
1097, 4nkzD, 0.8225, 3.45, 0.156, 465, 384, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
1098, 4ejgF, 0.8225, 3.21, 0.152, 465, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1099, 3ua5A, 0.8225, 3.49, 0.151, 465, 385, CRYSTAL STRUCTURE OF P450 2B6 (Y226H/K262R) IN COMPLEX WITH TWO MOLECULES OF AMLODIPINE
1100, 3wrkD, 0.8224, 2.56, 0.226, 392, 363, CRYSTAL STRUCTURE OF P450CAM
1101, 3t3rB, 0.8224, 3.21, 0.168, 463, 380, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
1102, 3rukC, 0.8224, 3.48, 0.158, 472, 385, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
1103, 5jq2B, 0.8223, 3.44, 0.126, 459, 381, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH N-PALMITOYLGLYCINE
1104, 1z10A, 0.8223, 3.22, 0.163, 465, 380, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
1105, 4kq8A, 0.8222, 3.44, 0.167, 452, 383, STRUCTURE OF RECOMBINANT HUMAN CYTOCHROME P450 AROMATASE
1106, 4ggvA, 0.8222, 3.09, 0.216, 396, 371, CRYSTAL STRUCTURE OF HMTT INVOLVED IN HIMASTATIN BIOSYNTHESIS
1107, 2p85D, 0.8222, 3.21, 0.155, 464, 380, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1108, 5kyoA, 0.8221, 3.02, 0.199, 394, 376, CRYSTAL STRUCTURE OF CYP101J2
1109, 5k7kA, 0.8220, 3.44, 0.151, 455, 384, DESIGN AND OPTIMIZATION OF BIARYL ETHER ARYL SULFONAMIDES AS SELECTIVE INHIBITORS OF NAV1.7: DISCOVERY OF CLINICAL CANDIDATE PF-05089771
1110, 5jl9A, 0.8220, 3.45, 0.167, 452, 383, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #4
1111, 5b2xA, 0.8220, 3.43, 0.121, 453, 380, CRYSTAL STRUCTURE OF P450BM3 MUTANT WITH N-PERFLUOROHEPTANOYL-L- TRYPTOPHAN
1112, 3ekfA, 0.8220, 3.34, 0.119, 441, 377, CRYSTAL STRUCTURE OF THE A264Q HEME DOMAIN OF CYTOCHROME P450 BM3
1113, 3dgiA, 0.8220, 3.35, 0.122, 449, 378, CRYSTAL STRUCTURE OF F87A/T268A MUTANT OF CYP BM3
1114, 6f85B, 0.8218, 3.16, 0.204, 392, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH HISTIDINE
1115, 5jkwA, 0.8218, 3.45, 0.167, 452, 383, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) COMPLEXED WITH TESTOSTERONE
1116, 4uymA, 0.8218, 3.49, 0.199, 470, 386, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VORICONAZOLE
1117, 3ebsA, 0.8218, 3.26, 0.171, 465, 381, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
1118, 2x7yA, 0.8218, 3.34, 0.124, 437, 378, P450 BM3 F87A IN COMPLEX WITH DMSO
1119, 2pg6A, 0.8218, 3.22, 0.163, 465, 380, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
1120, 6f8aB, 0.8217, 3.15, 0.204, 394, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH HISTIDINE
1121, 5jl7A, 0.8217, 3.45, 0.167, 452, 383, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #3
1122, 5jl6A, 0.8217, 3.44, 0.167, 452, 383, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #2
1123, 4h24B, 0.8217, 3.31, 0.138, 452, 377, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
1124, 6f8cA, 0.8216, 3.16, 0.204, 394, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH PROGESTERONE
1125, 5ucwB, 0.8216, 3.30, 0.125, 453, 377, CYTOCHROME P411 P-4 A82L A78V F263L AMINATION CATALYST
1126, 4kf0A, 0.8216, 3.43, 0.126, 451, 380, STRUCTURE OF THE A82F P450 BM3 HEME DOMAIN
1127, 4ejgH, 0.8216, 3.20, 0.172, 458, 378, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1128, 3ua5B, 0.8216, 3.50, 0.151, 462, 385, CRYSTAL STRUCTURE OF P450 2B6 (Y226H/K262R) IN COMPLEX WITH TWO MOLECULES OF AMLODIPINE
1129, 6b82B, 0.8215, 3.44, 0.154, 470, 383, ZEBRA FISH CYP-450 17A1 MUTANT ABIRATERONE COMPLEX
1130, 4l36A, 0.8215, 3.49, 0.221, 396, 384, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 ENZYME TXTE
1131, 5kdzA, 0.8214, 3.08, 0.199, 393, 371, THE CRYSTAL STRUCTURE OF THE T252A MUTANT OF CYP199A4 IN COMPLEX WITH 4-METHOXYBENZOATE
1132, 4xryA, 0.8214, 3.23, 0.156, 464, 378, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
1133, 2fdyA, 0.8214, 3.23, 0.163, 465, 380, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
1134, 4wnvC, 0.8213, 3.22, 0.162, 454, 377, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
1135, 4i4hA, 0.8213, 3.38, 0.160, 457, 381, CRYSTAL STRUCTURE OF CYP3A4 LIGATED TO PYRIDINE-SUBSTITUTED DESOXYRITONAVIR
1136, 3t3rD, 0.8213, 3.24, 0.166, 464, 380, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
1137, 3s7sA, 0.8213, 3.45, 0.167, 452, 383, CRYSTAL STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH BREAST CANCER DRUG EXEMESTANE
1138, 2p85C, 0.8213, 3.25, 0.157, 464, 381, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1139, 6f88A, 0.8212, 3.10, 0.202, 394, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH PROGESTERONE
1140, 5eacA, 0.8212, 3.46, 0.182, 530, 385, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR R-TEBUCONAZOLE
1141, 4k9wB, 0.8212, 3.38, 0.160, 457, 381, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1142, 4hggB, 0.8212, 3.44, 0.118, 441, 380, CRYSTAL STRUCTURE OF P450 BM3 5F5R HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
1143, 4d7dA, 0.8212, 3.36, 0.157, 458, 381, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
1144, 4hggA, 0.8211, 3.44, 0.121, 435, 380, CRYSTAL STRUCTURE OF P450 BM3 5F5R HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
1145, 3t3sE, 0.8211, 3.24, 0.155, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1146, 5jkvA, 0.8209, 3.46, 0.167, 452, 383, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) AT 2.75 ANGSTROM WITH BOUND POLYETHYLENE GLYCOL
1147, 4wmzA, 0.8209, 3.48, 0.184, 527, 385, S. CEREVISIAE CYP51 COMPLEXED WITH FLUCONAZOLE IN THE ACTIVE SITE
1148, 4rsnB, 0.8209, 3.47, 0.121, 460, 381, CRYSTAL STRUCTURE OF THE E267V MUTANT OF CYTOCHROME P450 BM3
1149, 4rsnA, 0.8209, 3.47, 0.121, 460, 381, CRYSTAL STRUCTURE OF THE E267V MUTANT OF CYTOCHROME P450 BM3
1150, 4o4pA, 0.8209, 3.44, 0.126, 450, 380, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH S-OMEPRAZOL
1151, 4hgfA, 0.8209, 3.44, 0.118, 442, 380, CRYSTAL STRUCTURE OF P450 BM3 5F5K HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
1152, 4ze3A, 0.8208, 3.49, 0.184, 526, 385, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140H MUTANT COMPLEXED WITH FLUCONAZOLE
1153, 3s79A, 0.8208, 3.40, 0.160, 452, 382, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) REFINED AT 2.75 ANGSTROM
1154, 5hs1A, 0.8206, 3.52, 0.184, 528, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) COMPLEXED WITH VORICONAZOLE
1155, 5a5iA, 0.8206, 3.40, 0.154, 453, 382, CYTOCHROME 2C9 P450 INHIBITOR COMPLEX
1156, 5w0cA, 0.8205, 3.28, 0.151, 464, 377, CYTOCHROME P450 (CYP) 2C9 TCA007 INHIBITOR COMPLEX
1157, 5uvbA, 0.8205, 3.10, 0.202, 393, 371, THE CRYSTAL STRUCTURE OF 4-CYCLOPROPYLBENZOATE-BOUND CYP199A4
1158, 4wntB, 0.8205, 3.33, 0.166, 455, 379, HUMAN CYTOCHROME P450 2D6 AJMALICINE COMPLEX
1159, 3r1aD, 0.8205, 3.29, 0.131, 465, 381, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1160, 4hgfB, 0.8204, 3.45, 0.118, 441, 380, CRYSTAL STRUCTURE OF P450 BM3 5F5K HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
1161, 4gl5A, 0.8204, 3.40, 0.165, 452, 382, STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH DESIGNED INHIBITOR HDDG029 (COMPOUND 4)
1162, 4d78A, 0.8204, 3.33, 0.158, 459, 380, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
1163, 2fdyB, 0.8204, 3.25, 0.166, 464, 380, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
1164, 5esnA, 0.8203, 3.47, 0.182, 528, 385, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT STRUCTURE
1165, 5eseA, 0.8203, 3.53, 0.184, 528, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73R MUTANT COMPLEXED WITH FLUCONAZOLE
1166, 3t3sF, 0.8203, 3.28, 0.155, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1167, 3eqmA, 0.8203, 3.40, 0.160, 452, 382, CRYSTAL STRUCTURE OF HUMAN PLACENTAL AROMATASE CYTOCHROME P450 IN COMPLEX WITH ANDROSTENEDIONE
1168, 5esjA, 0.8202, 3.53, 0.181, 528, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G464S MUTANT COMPLEXED WITH FLUCONAZOLE
1169, 4gl7A, 0.8202, 3.34, 0.171, 452, 381, STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH DESIGNED INHIBITOR HDDG046 (COMPOUND 5)
1170, 2p85A, 0.8202, 3.26, 0.152, 464, 381, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1171, 5ul0A, 0.8201, 3.46, 0.187, 528, 384, S. CEREVISIAE CYP51 COMPLEXED WITH VT-1161
1172, 3r1aH, 0.8201, 3.25, 0.137, 464, 380, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1173, 5frbA, 0.8200, 3.44, 0.198, 470, 384, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH A TETRAZOLE-BASED INHIBITOR VT-1598
1174, 5esfA, 0.8200, 3.54, 0.184, 524, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73E MUTANT COMPLEXED WITH FLUCONAZOLE
1175, 4i3qA, 0.8200, 3.54, 0.159, 465, 384, CRYSTAL STRUCTURE OF HUMAN CYP3A4 COORDINATED TO A WATER MOLECULE
1176, 3wrkA, 0.8200, 2.56, 0.224, 391, 362, CRYSTAL STRUCTURE OF P450CAM
1177, 1smiA, 0.8200, 3.31, 0.120, 439, 375, A SINGLE MUTATION OF P450 BM3 INDUCES THE CONFORMATIONAL REARRANGEMENT SEEN UPON SUBSTRATE-BINDING IN WILD-TYPE ENZYME
1178, 5d40A, 0.8198, 3.51, 0.211, 403, 383, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176Y MUTANT OF CYTOCHROME TXTE
1179, 4kf0B, 0.8198, 3.43, 0.121, 441, 379, STRUCTURE OF THE A82F P450 BM3 HEME DOMAIN
1180, 3nxuA, 0.8198, 3.39, 0.160, 457, 381, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P4503A4 BOUND TO AN INHIBITOR RITONAVIR
1181, 4ze2A, 0.8197, 3.47, 0.185, 529, 384, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140H MUTANT COMPLEXED WITH ITRACONAZOLE
1182, 5eagA, 0.8196, 3.48, 0.182, 528, 385, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR PROCHLORAZ
1183, 5eafA, 0.8196, 3.53, 0.181, 528, 386, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR FLUQUINCONAZOLE
1184, 5d3uA, 0.8196, 3.51, 0.211, 403, 383, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176F MUTANT OF CYTOCHROME TXTE
1185, 4lxjA, 0.8196, 3.47, 0.182, 530, 385, SACCHAROMYCES CEREVISIAE LANOSTEROL 14-ALPHA DEMETHYLASE WITH LANOSTEROL BOUND
1186, 3r1aA, 0.8196, 3.24, 0.137, 465, 380, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1187, 6cr2B, 0.8195, 3.46, 0.197, 469, 385, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM ASPERGILLUS FUMIGATUS IN COMPLEX WITH THE VNI DERIVATIVE N-(1-(2;4- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-(2-FLUORO-4-(2;2;2- TRIFLUOROETHOXY)PHENYL)-1;3;4-OXADIAZOL-2-YL)BENZAMIDE 
1188, 5eskA, 0.8195, 3.49, 0.182, 527, 385, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G464S MUTANT COMPLEXED WITH ITRACONAZOLE
1189, 5eadA, 0.8195, 3.53, 0.184, 529, 386, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR S-DESTHIO-PROTHIOCONAZOLE
1190, 4ze1A, 0.8195, 3.49, 0.184, 528, 385, SACCHAROMYCES CEREVISIAE CYP51 Y140F MUTANT COMPLEXED WITH POSACONAZOLE IN THE ACTIVE SITE
1191, 4wnvD, 0.8195, 3.15, 0.168, 453, 376, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
1192, 4tpoA, 0.8195, 3.60, 0.221, 398, 385, HIGH-RESOLUTION STRUCTURE OF TXTE WITH BOUND TRYPTOPHAN SUBSTRATE
1193, 2q6nB, 0.8195, 3.28, 0.155, 465, 381, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1194, 3r1aG, 0.8194, 3.29, 0.139, 465, 381, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1195, 2wuzA, 0.8194, 3.23, 0.172, 444, 378, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE IN ALTERNATIVE CONFORMATION
1196, 3k1oA, 0.8193, 3.44, 0.157, 442, 381, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH A POTENTIAL ANTICHAGASIC DRUG POSACONAZOLE
1197, 5eahA, 0.8192, 3.54, 0.181, 529, 386, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR DIFENOCONAZOLE
1198, 4uhlF, 0.8192, 3.41, 0.160, 445, 381, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
1199, 3qi8B, 0.8192, 3.34, 0.135, 452, 377, EVOLVED VARIANT OF CYTOCHROME P450 (BM3 CYP102A1)
1200, 2p85F, 0.8192, 3.29, 0.157, 464, 381, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1201, 2l8mA, 0.8192, 3.10, 0.208, 405, 375, REDUCED AND CO-BOUND CYTOCHROME P450CAM (CYP101A1)
1202, 5a1pA, 0.8191, 3.51, 0.161, 465, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 3A4 BOUND TO PROGESTERONE AND CITRATE
1203, 4uylA, 0.8191, 3.54, 0.194, 470, 387, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VNI
1204, 1suoA, 0.8191, 3.39, 0.157, 465, 381, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4 WITH BOUND 4-(4- CHLOROPHENYL)IMIDAZOLE
1205, 5eabA, 0.8190, 3.55, 0.184, 525, 386, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR S-TEBUCONAZOLE
1206, 1dt6A, 0.8190, 3.49, 0.141, 449, 383, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2C5
1207, 4wnvB, 0.8189, 3.20, 0.170, 455, 377, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
1208, 3tbgB, 0.8189, 3.32, 0.169, 456, 379, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
1209, 3kohB, 0.8189, 3.27, 0.163, 463, 380, CYTOCHROME P450 2E1 WITH OMEGA-IMIDAZOLYL OCTANOIC ACID
1210, 3ibdA, 0.8189, 3.43, 0.144, 465, 382, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2B6 GENETIC VARIANT IN COMPLEX WITH THE INHIBITOR 4-(4-CHLOROPHENYL)IMIDAZOLE
1211, 5tz1B, 0.8188, 3.56, 0.165, 484, 387, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM CANDIDA ALBICANS IN COMPLEX WITH THE TETRAZOLE-BASED ANTIFUNGAL DRUG CANDIDATE VT1161 (VT1)
1212, 4wnwB, 0.8188, 3.28, 0.153, 452, 378, HUMAN CYTOCHROME P450 2D6 THIORIDAZINE COMPLEX
1213, 5tftD, 0.8187, 3.18, 0.170, 453, 376, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1214, 3t3sH, 0.8187, 3.24, 0.155, 464, 380, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1215, 3r1aC, 0.8187, 3.30, 0.136, 465, 381, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1216, 3ld6B, 0.8187, 3.37, 0.158, 444, 380, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH KETOCONAZOLE
1217, 3tbgD, 0.8186, 3.32, 0.169, 456, 379, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
1218, 3nxuB, 0.8186, 3.41, 0.160, 457, 381, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P4503A4 BOUND TO AN INHIBITOR RITONAVIR
1219, 4r20B, 0.8185, 3.12, 0.177, 414, 373, ZEBRA FISH CYTOCHROME P450 17A2 WITH ABIRATERONE
1220, 5esmA, 0.8184, 3.49, 0.182, 528, 385, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT COMPLEXED WITH FLUCONAZOLE
1221, 5esgA, 0.8184, 3.51, 0.184, 526, 385, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73E MUTANT COMPLEXED WITH ITRACONAZOLE
1222, 4zv8A, 0.8184, 3.29, 0.126, 465, 381, STRUCTURE OF CYP2B6 (Y226H/K262R) WITH ADDITIONAL MUTATION Y244W IN COMPLEX WITH ALPHA-PINENE
1223, 3kohA, 0.8184, 3.30, 0.168, 463, 381, CYTOCHROME P450 2E1 WITH OMEGA-IMIDAZOLYL OCTANOIC ACID
1224, 5iuzB, 0.8183, 3.41, 0.160, 464, 381, STRUCTURE OF P450 2B4 F202W MUTANT (CYMAL-5)
1225, 5tfuD, 0.8182, 3.18, 0.170, 453, 376, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1226, 3r1aE, 0.8182, 3.28, 0.132, 465, 380, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1227, 2q6nC, 0.8182, 3.35, 0.149, 465, 382, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1228, 5kyoC, 0.8181, 2.98, 0.204, 390, 373, CRYSTAL STRUCTURE OF CYP101J2
1229, 5eslA, 0.8181, 3.45, 0.182, 527, 384, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT COMPLEXED WITH ITRACONAZOLE
1230, 5eshA, 0.8181, 3.55, 0.181, 528, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73W MUTANT IN COMPLEX WITH ITRACONAZOLE
1231, 5eafB, 0.8181, 3.55, 0.184, 528, 386, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR FLUQUINCONAZOLE
1232, 4ze0A, 0.8181, 3.45, 0.182, 530, 384, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH VORICONAZOLE
1233, 4zdzA, 0.8181, 3.46, 0.182, 529, 384, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH FLUCONAZOLE
1234, 5wbgB, 0.8180, 3.41, 0.139, 464, 381, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1235, 5vcgA, 0.8180, 3.49, 0.162, 461, 383, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO BROMOERGOCRYPTINE
1236, 3qu8A, 0.8180, 3.30, 0.144, 462, 381, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1237, 2q6nA, 0.8180, 3.28, 0.132, 465, 380, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1238, 5esiA, 0.8179, 3.50, 0.182, 530, 385, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73W MUTANT
1239, 5e58A, 0.8179, 3.33, 0.142, 464, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1240, 5ajrA, 0.8179, 3.35, 0.158, 449, 379, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE 1-TETRAZOLE DERIVATIVE VT-1161 ((R)-2-( 24-DIFLUOROPHENYL)-11-DIFLUORO-3-(1H-TETRAZOL-1-YL)-1-(5- (4-(222-TRIFLUOROETHOXY)PHENYL)PYRIDIN-2-YL)PROPAN-2-OL)
1241, 4xryB, 0.8179, 3.15, 0.157, 455, 375, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
1242, 5eaeA, 0.8178, 3.56, 0.184, 529, 386, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR R-DESTHIO-PROTHIOCONAZOLE
1243, 3g1qB, 0.8178, 3.39, 0.163, 444, 381, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
1244, 6aycA, 0.8177, 3.23, 0.168, 449, 376, NAEGLERIA FOWLERI CYP51-ITRACONAZOLE COMPLEX
1245, 5v5zA, 0.8177, 3.53, 0.171, 488, 385, STRUCTURE OF CYP51 FROM THE PATHOGEN CANDIDA ALBICANS
1246, 5tfuB, 0.8177, 3.14, 0.165, 451, 375, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1247, 3ld6A, 0.8177, 3.38, 0.158, 445, 380, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH KETOCONAZOLE
1248, 5wbgC, 0.8176, 3.42, 0.139, 464, 381, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1249, 4uymB, 0.8175, 3.54, 0.199, 470, 386, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VORICONAZOLE
1250, 3tk3A, 0.8175, 3.42, 0.160, 465, 381, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
1251, 3e6iA, 0.8175, 3.29, 0.161, 462, 380, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR INDAZOLE
1252, 5wbgF, 0.8174, 3.43, 0.134, 464, 381, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1253, 4uhiD, 0.8174, 3.43, 0.160, 442, 381, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
1254, 3r1aF, 0.8174, 3.33, 0.134, 465, 381, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1255, 3jusA, 0.8174, 3.40, 0.161, 445, 380, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH ECONAZOLE
1256, 2q6nG, 0.8174, 3.38, 0.152, 465, 381, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1257, 1tqnA, 0.8174, 3.56, 0.159, 468, 384, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 3A4
1258, 5tfuC, 0.8173, 3.16, 0.171, 450, 375, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1259, 5iutA, 0.8173, 3.55, 0.165, 460, 382, STRUCTURE OF P450 2B4 F202W MUTANT
1260, 3tk3C, 0.8173, 3.42, 0.157, 465, 381, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
1261, 2v0mA, 0.8173, 3.24, 0.159, 455, 377, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
1262, 3ekdB, 0.8172, 3.46, 0.129, 455, 380, CRYSTAL STRUCTURE OF THE A264M HEME DOMAIN OF CYTOCHROME P450 BM3
1263, 5e58D, 0.8171, 3.33, 0.142, 463, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1264, 5e58C, 0.8171, 3.31, 0.142, 465, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1265, 3tk3B, 0.8171, 3.42, 0.157, 465, 381, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
1266, 3tjsA, 0.8171, 3.14, 0.157, 449, 375, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN CYTOCHROME P450 3A4 AND DESTHIAZOLYLMETHYLOXYCARBONYL RITONAVIR
1267, 3gphB, 0.8171, 3.30, 0.168, 461, 380, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DECANOIC ACID
1268, 3e6iB, 0.8171, 3.32, 0.161, 461, 380, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR INDAZOLE
1269, 4zdyA, 0.8170, 3.53, 0.182, 527, 385, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH ITRACONAZOLE
1270, 4uylB, 0.8170, 3.55, 0.197, 470, 386, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VNI
1271, 4g3jA, 0.8170, 3.31, 0.166, 448, 380, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
1272, 3dgiB, 0.8170, 3.23, 0.126, 425, 373, CRYSTAL STRUCTURE OF F87A/T268A MUTANT OF CYP BM3
1273, 5wbgD, 0.8169, 3.44, 0.134, 464, 381, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1274, 3tk3D, 0.8169, 3.43, 0.157, 465, 381, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
1275, 5d3uB, 0.8168, 3.55, 0.211, 403, 383, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176F MUTANT OF CYTOCHROME TXTE
1276, 3ekdA, 0.8168, 3.45, 0.129, 454, 379, CRYSTAL STRUCTURE OF THE A264M HEME DOMAIN OF CYTOCHROME P450 BM3
1277, 5wbgA, 0.8166, 3.43, 0.142, 463, 381, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1278, 4uhiC, 0.8166, 3.44, 0.160, 442, 381, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
1279, 4i91A, 0.8166, 3.41, 0.134, 465, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH ALPHA-PINENE.
1280, 3lc4A, 0.8166, 3.26, 0.164, 460, 379, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DODECANOIC ACID
1281, 3gw9C, 0.8166, 3.32, 0.161, 449, 380, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
1282, 6cr2A, 0.8165, 3.56, 0.197, 469, 386, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM ASPERGILLUS FUMIGATUS IN COMPLEX WITH THE VNI DERIVATIVE N-(1-(2;4- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-(2-FLUORO-4-(2;2;2- TRIFLUOROETHOXY)PHENYL)-1;3;4-OXADIAZOL-2-YL)BENZAMIDE 
1283, 5tz1A, 0.8165, 3.47, 0.167, 484, 384, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM CANDIDA ALBICANS IN COMPLEX WITH THE TETRAZOLE-BASED ANTIFUNGAL DRUG CANDIDATE VT1161 (VT1)
1284, 3t3zB, 0.8165, 3.30, 0.168, 464, 380, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
1285, 3t3zA, 0.8165, 3.30, 0.171, 464, 380, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
1286, 3hf2B, 0.8165, 3.33, 0.131, 423, 375, CRYSTAL STRUCTURE OF THE I401P MUTANT OF CYTOCHROME P450 BM3
1287, 2v0mD, 0.8165, 3.28, 0.159, 453, 377, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
1288, 5udaA, 0.8164, 3.32, 0.139, 461, 380, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE BORNANE
1289, 5eqbA, 0.8164, 3.51, 0.182, 531, 385, CRYSTAL STRUCTURE OF LANOSTEROL 14-ALPHA DEMETHYLASE WITH INTACT TRANSMEMBRANE DOMAIN BOUND TO ITRACONAZOLE
1290, 2v0mB, 0.8164, 3.26, 0.159, 451, 377, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
1291, 5wbgE, 0.8163, 3.43, 0.142, 463, 381, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1292, 5d40B, 0.8163, 3.55, 0.211, 403, 383, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176Y MUTANT OF CYTOCHROME TXTE
1293, 3hf2A, 0.8163, 3.46, 0.125, 428, 377, CRYSTAL STRUCTURE OF THE I401P MUTANT OF CYTOCHROME P450 BM3
1294, 4gqsD, 0.8162, 3.19, 0.162, 452, 376, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
1295, 3me6D, 0.8162, 3.44, 0.157, 465, 381, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
1296, 3me6B, 0.8162, 3.45, 0.157, 465, 381, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
1297, 4uhlA, 0.8160, 3.45, 0.160, 445, 381, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
1298, 4ck8A, 0.8160, 3.32, 0.159, 449, 378, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (R)-1-(24-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL 4-(4-(34-DICHLOROPHENYL)PIPERAZIN-1-YL)PHENYLCARBAMATE (LFD)
1299, 3zg2A, 0.8159, 3.49, 0.155, 449, 381, STEROL 14 ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE PYRIDINE INHIBITOR (S)-2-(4-CHLOROPHENYL)-2- (PYRIDIN-3-YL)-1-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL) ETHANONE (EPL-BS1246UDO)
1300, 5tfuA, 0.8158, 3.22, 0.160, 451, 375, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1301, 5li7A, 0.8158, 2.79, 0.304, 373, 362, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH 1-(3-(1H-IMIDAZOL-1-YL)PROPYL)-3-((3S5S7S)-ADAMANTAN-1-YL)UREA
1302, 4uhlG, 0.8158, 3.46, 0.160, 445, 381, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
1303, 3r1aB, 0.8158, 3.33, 0.134, 465, 381, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1304, 3me6C, 0.8158, 3.46, 0.163, 465, 381, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
1305, 5uapA, 0.8157, 3.43, 0.134, 464, 381, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH BORNYL BROMIDE
1306, 5li7B, 0.8157, 2.75, 0.302, 372, 361, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH 1-(3-(1H-IMIDAZOL-1-YL)PROPYL)-3-((3S5S7S)-ADAMANTAN-1-YL)UREA
1307, 5e58E, 0.8157, 3.37, 0.139, 462, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1308, 4g7gB, 0.8157, 3.34, 0.166, 448, 380, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
1309, 3t3zD, 0.8157, 3.32, 0.168, 464, 380, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
1310, 3t3zC, 0.8157, 3.31, 0.168, 464, 380, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
1311, 2q6nF, 0.8157, 3.42, 0.155, 465, 381, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1312, 5uapB, 0.8156, 3.44, 0.134, 463, 381, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH BORNYL BROMIDE
1313, 4uhlE, 0.8156, 3.39, 0.161, 445, 380, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
1314, 3me6A, 0.8156, 3.45, 0.163, 465, 381, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
1315, 5a1rA, 0.8155, 3.59, 0.149, 462, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 3A4 BOUND TO PROGESTERONE
1316, 5iuzA, 0.8154, 3.34, 0.156, 459, 379, STRUCTURE OF P450 2B4 F202W MUTANT (CYMAL-5)
1317, 4xryD, 0.8154, 3.19, 0.158, 452, 374, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
1318, 4cohB, 0.8154, 3.42, 0.164, 445, 379, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE SULFONAMIDE DERIVATIVE OF THE 4-AMINOPYRIDYL-BASED INHIBITOR
1319, 3qu8C, 0.8154, 3.41, 0.142, 462, 381, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1320, 3e4eA, 0.8154, 3.30, 0.164, 461, 379, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR 4- METHYLPYRAZOLE
1321, 5uecA, 0.8153, 3.43, 0.134, 465, 381, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH MYRTENYL BROMIDE.
1322, 4uhiA, 0.8153, 3.46, 0.160, 442, 381, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
1323, 4rrtA, 0.8153, 3.37, 0.134, 461, 380, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH (+)-3-CARENE
1324, 3jusB, 0.8153, 3.38, 0.158, 445, 380, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH ECONAZOLE
1325, 6bd7A, 0.8151, 3.54, 0.159, 462, 383, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1326, 4uhlC, 0.8151, 3.46, 0.157, 445, 381, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
1327, 4d75A, 0.8150, 3.56, 0.154, 460, 383, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
1328, 3zg3A, 0.8150, 3.31, 0.162, 445, 377, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE PYRIDINE INHIBITOR N-(1-(5-( TRIFLUOROMETHYL)(PYRIDIN-2-YL))PIPERIDIN-4YL)-N-(4-( TRIFLUOROMETHYL)PHENYL)PYRIDIN-3-AMINE (EPL-BS967 UDD)
1329, 5livC, 0.8149, 3.07, 0.203, 395, 370, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1330, 4wnuC, 0.8149, 3.28, 0.157, 452, 376, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
1331, 4uhlB, 0.8149, 3.40, 0.155, 445, 380, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
1332, 5ufgA, 0.8148, 3.44, 0.142, 464, 381, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R/I114V) IN COMPLEX WITH MYRTENYL BROMIDE
1333, 3uasA, 0.8148, 3.41, 0.158, 461, 380, CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR 9-ETHYNYLPHENANTHRENE
1334, 3lc4B, 0.8148, 3.26, 0.164, 459, 378, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DODECANOIC ACID
1335, 4rrtB, 0.8147, 3.38, 0.134, 461, 380, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH (+)-3-CARENE
1336, 4rqlB, 0.8147, 3.46, 0.136, 465, 382, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE - SABINENE
1337, 4rqlA, 0.8147, 3.46, 0.136, 465, 382, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE - SABINENE
1338, 6bczA, 0.8146, 3.45, 0.160, 461, 381, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1339, 3kw4A, 0.8146, 3.50, 0.157, 466, 382, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG TICLOPIDINE
1340, 3e4eB, 0.8146, 3.31, 0.161, 461, 379, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR 4- METHYLPYRAZOLE
1341, 6ay4A, 0.8145, 3.28, 0.162, 450, 376, NAEGLERIA FOWLERI CYP51-FLUCONAZOLE COMPLEX
1342, 4uhlH, 0.8145, 3.41, 0.163, 445, 380, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
1343, 5udaB, 0.8144, 3.33, 0.140, 460, 379, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE BORNANE
1344, 4wnuA, 0.8144, 3.22, 0.157, 449, 375, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
1345, 4c28A, 0.8144, 3.41, 0.161, 443, 379, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)- 2-FLUOROBENZAMIDE.
1346, 5fsaA, 0.8143, 3.53, 0.164, 484, 385, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM A PATHOGENIC YEAST CANDIDA ALBICANS IN COMPLEX WITH THE ANTIFUNGAL DRUG POSACONAZOLE
1347, 4k9xA, 0.8143, 3.45, 0.161, 449, 379, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1348, 6b82A, 0.8142, 3.48, 0.150, 465, 380, ZEBRA FISH CYP-450 17A1 MUTANT ABIRATERONE COMPLEX
1349, 4c27B, 0.8142, 3.34, 0.164, 443, 377, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-2- FLUORO-4-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL)BENZAMIDE
1350, 4c27A, 0.8142, 3.42, 0.161, 444, 379, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-2- FLUORO-4-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL)BENZAMIDE
1351, 5vcdA, 0.8141, 3.48, 0.163, 460, 381, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO GLYCEROL
1352, 4uhiB, 0.8141, 3.48, 0.157, 442, 381, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
1353, 4h6oA, 0.8141, 3.47, 0.161, 435, 380, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE INHIBITOR NEU321 (1-(3-(4-CHLORO-35-DIMETHYLPHENOXY) BENZYL)-1H-IMIDAZOLE
1354, 4k9vA, 0.8140, 3.35, 0.161, 456, 378, COMPLEX OF CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1355, 4cohA, 0.8140, 3.38, 0.164, 442, 378, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE SULFONAMIDE DERIVATIVE OF THE 4-AMINOPYRIDYL-BASED INHIBITOR
1356, 3qoaA, 0.8140, 3.28, 0.138, 460, 378, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-BENZYLPYRIDINE.
1357, 4bmmB, 0.8139, 3.37, 0.161, 442, 378, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
1358, 6f85A, 0.8138, 3.21, 0.212, 392, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH HISTIDINE
1359, 5fsaB, 0.8138, 3.55, 0.164, 483, 385, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM A PATHOGENIC YEAST CANDIDA ALBICANS IN COMPLEX WITH THE ANTIFUNGAL DRUG POSACONAZOLE
1360, 3qu8B, 0.8138, 3.27, 0.146, 459, 378, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1361, 3gphA, 0.8138, 3.39, 0.165, 461, 381, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DECANOIC ACID
1362, 6bdiA, 0.8136, 3.45, 0.160, 462, 381, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1363, 3qu8D, 0.8136, 3.26, 0.143, 458, 378, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1364, 2wuzB, 0.8136, 3.33, 0.165, 444, 376, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE IN ALTERNATIVE CONFORMATION
1365, 4wnuD, 0.8135, 3.28, 0.170, 450, 376, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
1366, 4ckaA, 0.8135, 3.38, 0.161, 434, 378, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (S)-1-(4-FLUOROPHENYL)-2-(1H-IMIDAZOL-1-YL) ETHYL 4-ISOPROPYLPHENYLCARBAMATE (LFS)
1367, 6bd5A, 0.8134, 3.42, 0.161, 457, 380, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1368, 4wnuB, 0.8134, 3.32, 0.167, 453, 377, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
1369, 4bmmA, 0.8134, 3.38, 0.161, 441, 378, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
1370, 3qu8E, 0.8134, 3.27, 0.146, 459, 378, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1371, 3nc6B, 0.8134, 3.15, 0.239, 389, 368, CYP134A1 1-PHENYLIMIDAZOLE BOUND STRUCTURE
1372, 3khmA, 0.8134, 3.49, 0.164, 441, 379, CRYSTAL STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH INHIBITOR FLUCONAZOLE
1373, 6f8cB, 0.8133, 3.17, 0.208, 394, 371, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH PROGESTERONE
1374, 6bd8A, 0.8131, 3.40, 0.161, 457, 380, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1375, 5em4A, 0.8131, 3.48, 0.161, 460, 379, STRUCTURE OF CYP2B4 F244W IN A LIGAND FREE CONFORMATION
1376, 4uhlD, 0.8131, 3.42, 0.163, 445, 380, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
1377, 4ck8B, 0.8131, 3.41, 0.168, 450, 380, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (R)-1-(24-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL 4-(4-(34-DICHLOROPHENYL)PIPERAZIN-1-YL)PHENYLCARBAMATE (LFD)
1378, 4ck9A, 0.8130, 3.44, 0.161, 434, 379, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (S)-1-(4-CHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL) ETHYL 4-ISOPROPYLPHENYLCARBAMATE (LFT)
1379, 4c28B, 0.8130, 3.45, 0.158, 441, 379, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)- 2-FLUOROBENZAMIDE.
1380, 4bjkD, 0.8130, 3.43, 0.158, 444, 379, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
1381, 5jlcA, 0.8129, 3.55, 0.177, 506, 384, STRUCTURE OF CYP51 FROM THE PATHOGEN CANDIDA GLABRATA
1382, 5em4B, 0.8129, 3.48, 0.161, 459, 379, STRUCTURE OF CYP2B4 F244W IN A LIGAND FREE CONFORMATION
1383, 4jltA, 0.8129, 3.33, 0.162, 458, 377, CRYSTAL STRUCTURE OF P450 2B4(H226Y) IN COMPLEX WITH PAROXETINE
1384, 3l4dB, 0.8129, 3.34, 0.178, 449, 377, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
1385, 2x2nC, 0.8127, 3.37, 0.161, 441, 378, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
1386, 4l36B, 0.8126, 3.61, 0.215, 392, 382, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 ENZYME TXTE
1387, 4h1nA, 0.8126, 3.43, 0.159, 459, 378, CRYSTAL STRUCTURE OF P450 2B4 F297A MUTANT IN COMPLEX WITH ANTI- PLATELET DRUG CLOPIDOGREL
1388, 3tikB, 0.8126, 3.42, 0.161, 450, 378, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
1389, 2x2nD, 0.8126, 3.43, 0.161, 447, 379, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
1390, 6ay6A, 0.8125, 3.29, 0.163, 448, 375, NAEGLERIA FOWLERI CYP51-VORICONAZOLE COMPLEX
1391, 3g1qD, 0.8125, 3.35, 0.167, 448, 378, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
1392, 5vccA, 0.8124, 3.49, 0.160, 457, 381, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO GLYCEROL
1393, 1w0fA, 0.8124, 3.47, 0.158, 459, 379, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
1394, 3tikC, 0.8123, 3.51, 0.158, 450, 379, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
1395, 5veuL, 0.8122, 3.34, 0.149, 448, 377, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1396, 4k9tA, 0.8121, 3.45, 0.161, 455, 378, COMPLEX OF CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1397, 5kyoD, 0.8120, 2.95, 0.189, 384, 370, CRYSTAL STRUCTURE OF CYP101J2
1398, 5tftC, 0.8119, 3.13, 0.167, 447, 372, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1399, 6bd6A, 0.8118, 3.46, 0.161, 457, 380, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1400, 4xryC, 0.8117, 3.14, 0.161, 446, 372, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
1401, 4bjkC, 0.8117, 3.39, 0.159, 450, 378, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
1402, 3g1qC, 0.8117, 3.34, 0.159, 447, 377, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
1403, 4g7gD, 0.8116, 3.41, 0.161, 448, 378, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
1404, 4g7gC, 0.8116, 3.35, 0.175, 448, 378, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
1405, 3l4dD, 0.8116, 3.36, 0.172, 445, 377, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
1406, 2wv2A, 0.8116, 3.36, 0.159, 443, 377, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA BRUCEI IN COMPLEX WITH FLUCONAZOLE
1407, 2q6nE, 0.8116, 3.39, 0.134, 465, 380, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1408, 2q6nD, 0.8116, 3.43, 0.155, 465, 381, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1409, 6bdkA, 0.8115, 3.51, 0.160, 461, 381, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1410, 2x2nA, 0.8115, 3.34, 0.159, 448, 377, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
1411, 4g3jC, 0.8114, 3.50, 0.161, 448, 379, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
1412, 3p99C, 0.8114, 3.49, 0.158, 444, 379, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
1413, 3l4dA, 0.8114, 3.44, 0.187, 448, 379, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
1414, 5vceA, 0.8112, 3.54, 0.161, 457, 380, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO RITONAVIR
1415, 4d6zA, 0.8112, 3.42, 0.161, 460, 379, CYTOCHROME P450 3A4 BOUND TO IMIDAZOLE AND AN INHIBITOR
1416, 4bmmD, 0.8110, 3.53, 0.158, 442, 379, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
1417, 3ua1A, 0.8110, 3.52, 0.150, 456, 380, CRYSTAL STRUCTURE OF THE CYTOCHROME P4503A4-BROMOERGOCRYPTINE COMPLEX
1418, 3mvrB, 0.8110, 3.52, 0.161, 463, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4-H226Y IN A CLOSED CONFORMATION
1419, 5e58B, 0.8108, 3.34, 0.164, 458, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1420, 6f8aA, 0.8107, 3.21, 0.208, 394, 371, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH HISTIDINE
1421, 3mvrA, 0.8107, 3.53, 0.161, 463, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4-H226Y IN A CLOSED CONFORMATION
1422, 5tl8A, 0.8106, 3.27, 0.168, 448, 374, NAEGLERIA FOWLERI CYP51-POSACONAZOLE COMPLEX
1423, 4mgjA, 0.8106, 3.22, 0.158, 452, 374, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 F429H IN COMPLEX WITH 4-CPI
1424, 4g3jD, 0.8106, 3.42, 0.161, 448, 378, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
1425, 3nc3B, 0.8106, 3.02, 0.236, 385, 364, CYP134A1 STRUCTURE WITH A CLOSED SUBSTRATE BINDING LOOP
1426, 6f88B, 0.8105, 3.16, 0.205, 393, 370, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH PROGESTERONE
1427, 4bjkB, 0.8105, 3.36, 0.159, 450, 377, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
1428, 3juvA, 0.8105, 3.42, 0.156, 448, 379, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51)
1429, 4rm4A, 0.8104, 2.42, 0.302, 364, 354, THE CRYSTAL STRUCTURE OF THE VERSATILE CYTOCHROME P450 ENZYME CYP109B1 FROM BACILLUS SUBTILIS
1430, 2x2nB, 0.8104, 3.43, 0.161, 444, 378, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
1431, 3p99D, 0.8103, 3.49, 0.163, 448, 381, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
1432, 4ny4A, 0.8099, 3.56, 0.158, 460, 380, CRYSTAL STRUCTURE OF CYP3A4 IN COMPLEX WITH AN INHIBITOR
1433, 3gw9A, 0.8098, 3.43, 0.161, 450, 378, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
1434, 3tikA, 0.8097, 3.38, 0.159, 450, 377, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
1435, 3gw9D, 0.8097, 3.45, 0.172, 449, 379, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
1436, 3qu8F, 0.8096, 3.26, 0.144, 453, 376, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1437, 3nc7B, 0.8096, 2.91, 0.237, 384, 363, CYP134A1 2-PHENYLIMIDAZOLE BOUND STRUCTURE
1438, 2f9qC, 0.8096, 3.51, 0.169, 454, 378, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
1439, 6bdmA, 0.8094, 3.60, 0.160, 456, 381, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1440, 4by0A, 0.8094, 3.39, 0.159, 441, 377, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-(11 -BIPHENYL)-4- CARBOXAMIDE
1441, 3gw9B, 0.8094, 3.57, 0.155, 449, 380, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
1442, 3p99A, 0.8092, 3.53, 0.163, 448, 381, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
1443, 4g3jB, 0.8091, 3.57, 0.155, 448, 380, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
1444, 4r20A, 0.8090, 3.31, 0.180, 406, 373, ZEBRA FISH CYTOCHROME P450 17A2 WITH ABIRATERONE
1445, 3g1qA, 0.8090, 3.43, 0.156, 448, 377, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
1446, 3l4dC, 0.8089, 3.34, 0.188, 447, 377, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
1447, 3p99B, 0.8087, 3.43, 0.159, 448, 378, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
1448, 4k9uA, 0.8086, 3.31, 0.163, 450, 374, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1449, 2lqdA, 0.8086, 3.26, 0.209, 405, 374, REDUCED AND CO-BOUND CYTOCHROME P450CAM (CYP101A1)
1450, 6aybA, 0.8085, 3.31, 0.168, 447, 374, NAEGLERIA FOWLERI CYP51-KETOCONAZOLE COMPLEX
1451, 4bjkA, 0.8084, 3.38, 0.162, 450, 377, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
1452, 2f9qA, 0.8084, 3.55, 0.172, 454, 379, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
1453, 4bmmC, 0.8081, 3.47, 0.162, 440, 377, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
1454, 4g7gA, 0.8080, 3.58, 0.158, 448, 380, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
1455, 3nc5A, 0.8080, 2.86, 0.238, 384, 361, CYP134A1 STRUCTURE WITH AN OPEN SUBSTRATE BINDING LOOP
1456, 2wx2A, 0.8080, 3.65, 0.166, 441, 380, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE
1457, 5livA, 0.8076, 3.29, 0.208, 397, 371, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1458, 4by0B, 0.8076, 3.44, 0.159, 442, 378, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-(11 -BIPHENYL)-4- CARBOXAMIDE
1459, 3k9yA, 0.8075, 3.58, 0.155, 461, 381, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CYMAL-5
1460, 4uvrA, 0.8073, 3.53, 0.158, 439, 379, BINDING MODE SELECTIVITY AND POTENCY OF N-INDOLYL- OXOPYRIDINYL-4-AMINO-PROPANYL-BASED INHIBITORS TARGETING TRYPANOSOMA CRUZI CYP51
1461, 3tikD, 0.8069, 3.37, 0.168, 450, 376, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
1462, 2f9qD, 0.8069, 3.51, 0.172, 451, 377, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
1463, 5kyoF, 0.8068, 3.01, 0.201, 383, 368, CRYSTAL STRUCTURE OF CYP101J2
1464, 5e58F, 0.8068, 3.34, 0.159, 457, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1465, 4c0cA, 0.8063, 3.56, 0.155, 446, 380, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(24-DIFLUOROPHENYL)PIPERAZIN-1- YL)-2-FLUOROBENZAMIDE.
1466, 3k9vA, 0.8063, 3.62, 0.152, 464, 381, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CHAPS
1467, 4uqhA, 0.8061, 3.54, 0.156, 443, 379, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(34-DIFLUOROPHENYL)PIPERAZIN-1- YL)-2-FLUOROBENZAMIDE.
1468, 5g5jA, 0.8059, 3.48, 0.160, 452, 376, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO METFORMIN
1469, 4tpnA, 0.8050, 3.49, 0.227, 386, 375, HIGH-RESOLUTION STRUCTURE OF TXTE IN THE ABSENCE OF SUBSTRATE
1470, 2f9qB, 0.8038, 3.41, 0.172, 451, 377, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
1471, 3nc7A, 0.8025, 2.84, 0.240, 379, 358, CYP134A1 2-PHENYLIMIDAZOLE BOUND STRUCTURE
1472, 3na1A, 0.8025, 3.60, 0.157, 472, 382, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 20- HYDROXYCHOLESTEROL
1473, 3na0A, 0.8024, 3.60, 0.154, 470, 382, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 2022- DIHYDROXYCHOLESTEROL
1474, 5te8A, 0.8023, 3.56, 0.150, 470, 379, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
1475, 3k9yB, 0.8021, 3.66, 0.157, 462, 381, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CYMAL-5
1476, 5veuE, 0.8020, 3.36, 0.153, 441, 372, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1477, 4tvfA, 0.8017, 2.47, 0.286, 352, 350, OXYB FROM ACTINOPLANES TEICHOMYCETICUS
1478, 3na0B, 0.8017, 3.62, 0.160, 470, 382, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 2022- DIHYDROXYCHOLESTEROL
1479, 2vkuA, 0.8017, 3.41, 0.173, 444, 375, 44 -DIHYDROXYBENZOPHENONE MIMICS STEROL SUBSTRATE IN THE BINDING SITE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) IN THE X-RAY STRUCTURE OF THE COMPLEX
1480, 3n9zA, 0.8015, 3.61, 0.157, 470, 382, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 22- HYDROXYCHOLESTEROL
1481, 3mzsC, 0.8015, 3.41, 0.153, 470, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
1482, 3k9vB, 0.8014, 3.68, 0.155, 464, 381, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CHAPS
1483, 3n9yA, 0.8013, 3.61, 0.154, 471, 382, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH CHOLESTEROL
1484, 3n9yB, 0.8011, 3.62, 0.162, 470, 382, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH CHOLESTEROL
1485, 5te8C, 0.8010, 3.53, 0.140, 469, 378, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
1486, 5te8B, 0.8010, 3.59, 0.163, 471, 380, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
1487, 3na1B, 0.8010, 3.63, 0.157, 471, 382, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 20- HYDROXYCHOLESTEROL
1488, 3n9zB, 0.8008, 3.63, 0.162, 470, 382, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 22- HYDROXYCHOLESTEROL
1489, 1w0gA, 0.8008, 3.54, 0.157, 455, 375, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
1490, 3mzsD, 0.8006, 3.43, 0.158, 470, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
1491, 2wx2B, 0.8005, 3.77, 0.164, 444, 379, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE
1492, 3nc3A, 0.8000, 2.78, 0.239, 380, 356, CYP134A1 STRUCTURE WITH A CLOSED SUBSTRATE BINDING LOOP
1493, 3mzsA, 0.8000, 3.45, 0.158, 470, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
1494, 3mzsB, 0.7998, 3.43, 0.153, 470, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
1495, 3r1bA, 0.7988, 3.66, 0.161, 465, 380, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1496, 2j0dA, 0.7985, 3.38, 0.158, 446, 373, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH ERYTHROMYCIN
1497, 3kswA, 0.7971, 3.65, 0.164, 444, 379, CRYSTAL STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH AN INHIBITOR VNF ((4-(4- CHLOROPHENYL)-N-[2-(1H-IMIDAZOL-1-YL)-1-PHENYLETHYL]BENZAMIDE)
1498, 1io9A, 0.7969, 2.49, 0.259, 366, 344, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1499, 6bdhA, 0.7962, 3.23, 0.161, 439, 367, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1500, 4fdhF, 0.7960, 3.55, 0.159, 469, 378, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1501, 3psxB, 0.7960, 3.22, 0.129, 414, 363, CRYSTAL STRUCTURE OF THE KT2 MUTANT OF CYTOCHROME P450 BM3
1502, 3nc5B, 0.7959, 2.79, 0.242, 373, 355, CYP134A1 STRUCTURE WITH AN OPEN SUBSTRATE BINDING LOOP
1503, 4dvqF, 0.7957, 3.56, 0.161, 469, 378, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1504, 5hiwA, 0.7953, 3.44, 0.209, 391, 373, SORANGIUM CELLULOSUM SO CE56 CYTOCHROME P450 260B1
1505, 3dskA, 0.7953, 3.50, 0.129, 466, 371, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 1.55 A RESOLUTION
1506, 3dsjA, 0.7952, 3.50, 0.129, 465, 371, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.60 A RESOLUTION
1507, 3dsiA, 0.7952, 3.50, 0.129, 466, 371, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOT AT 1.60 A RESOLUTION
1508, 2rchA, 0.7952, 3.51, 0.129, 465, 371, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.85 A RESOLUTION
1509, 3r1bB, 0.7950, 3.69, 0.164, 465, 379, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1510, 3cliA, 0.7950, 3.53, 0.129, 465, 371, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) AT 1.80 A RESOLUTION
1511, 3nc6A, 0.7949, 2.81, 0.242, 374, 355, CYP134A1 1-PHENYLIMIDAZOLE BOUND STRUCTURE
1512, 4zgxK, 0.7948, 3.62, 0.161, 461, 379, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1513, 2rcmA, 0.7948, 3.46, 0.124, 465, 370, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A) AT 1.73 A RESOLUTION
1514, 1io7A, 0.7946, 2.51, 0.256, 366, 344, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1515, 4dvqE, 0.7943, 3.60, 0.164, 470, 379, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1516, 4zgxB, 0.7941, 3.62, 0.158, 465, 379, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1517, 2rclA, 0.7941, 3.47, 0.124, 465, 370, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 2.4 A RESOLUTION
1518, 4zgxC, 0.7938, 3.62, 0.158, 465, 379, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1519, 4fdhE, 0.7936, 3.65, 0.163, 470, 380, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1520, 4dvqG, 0.7936, 3.57, 0.161, 462, 378, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1521, 1io8A, 0.7936, 2.53, 0.256, 366, 344, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1522, 4fdhB, 0.7935, 3.63, 0.164, 465, 379, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1523, 4fdhG, 0.7934, 3.64, 0.158, 463, 380, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1524, 3psxA, 0.7933, 3.29, 0.138, 412, 363, CRYSTAL STRUCTURE OF THE KT2 MUTANT OF CYTOCHROME P450 BM3
1525, 2j0dB, 0.7932, 3.28, 0.160, 445, 368, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH ERYTHROMYCIN
1526, 4fdhD, 0.7927, 3.60, 0.167, 465, 378, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1527, 4fdhK, 0.7925, 3.56, 0.162, 469, 377, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1528, 4fdhA, 0.7923, 3.64, 0.164, 463, 379, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1529, 4dvqA, 0.7923, 3.69, 0.161, 463, 380, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1530, 4zgxA, 0.7922, 3.55, 0.164, 465, 377, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1531, 4zgxD, 0.7921, 3.56, 0.162, 465, 377, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1532, 4dvqC, 0.7919, 3.61, 0.161, 462, 378, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1533, 1w0eA, 0.7919, 3.50, 0.159, 450, 370, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
1534, 4zgxG, 0.7914, 3.64, 0.164, 465, 379, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1535, 4dvqH, 0.7914, 3.65, 0.161, 462, 378, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1536, 4dvqB, 0.7914, 3.66, 0.164, 463, 379, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1537, 4zgxJ, 0.7911, 3.57, 0.156, 463, 377, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1538, 4fdhC, 0.7906, 3.63, 0.161, 462, 378, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1539, 4dvqJ, 0.7906, 3.56, 0.165, 462, 376, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1540, 3g5nA, 0.7903, 3.73, 0.167, 456, 372, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1541, 4zgxL, 0.7902, 3.64, 0.161, 462, 378, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1542, 4zgxF, 0.7900, 3.63, 0.161, 464, 378, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1543, 4dvqD, 0.7900, 3.70, 0.164, 462, 379, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1544, 4wqjA, 0.7898, 2.36, 0.260, 367, 339, CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COLLECTED AT 298K AND COMPLEXED WITH 4-(4-BROMOPHENYL)-1H IMIDAZOLE
1545, 4zgxE, 0.7897, 3.54, 0.155, 459, 375, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1546, 4zgxH, 0.7895, 3.67, 0.164, 465, 379, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1547, 4fdhH, 0.7894, 3.66, 0.164, 462, 378, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1548, 5livB, 0.7893, 3.46, 0.216, 389, 371, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1549, 4tuvA, 0.7890, 2.38, 0.260, 367, 339, X-RAY CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COMPLEXED WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1550, 4fdhJ, 0.7890, 3.64, 0.162, 462, 377, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1551, 3dbmA, 0.7888, 3.61, 0.111, 467, 370, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
1552, 4tt5A, 0.7887, 2.39, 0.260, 367, 339, CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COMPLEXED WITH 4-(4-BROMOPHENYL)-1H IMIDAZOLE
1553, 4fdhI, 0.7886, 3.58, 0.162, 462, 376, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1554, 3danA, 0.7886, 3.64, 0.113, 473, 371, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
1555, 3r1bC, 0.7885, 3.69, 0.156, 456, 377, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1556, 5livD, 0.7884, 3.45, 0.215, 389, 367, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1557, 3b6hB, 0.7884, 3.63, 0.123, 470, 374, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE IN COMPLEX WITH INHIBITOR MINOXIDIL
1558, 4dvqI, 0.7883, 3.68, 0.164, 462, 378, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1559, 1ue8A, 0.7882, 2.51, 0.246, 367, 341, CRYSTAL STRUCTURE OF THERMOPHILIC CYTOCHROME P450 FROM SULFOLOBUS TOKODAII
1560, 3damA, 0.7881, 3.59, 0.111, 467, 370, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
1561, 3b6hA, 0.7876, 3.71, 0.125, 469, 375, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE IN COMPLEX WITH INHIBITOR MINOXIDIL
1562, 2iagB, 0.7875, 3.64, 0.120, 468, 374, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE
1563, 4fdhL, 0.7874, 3.58, 0.160, 456, 375, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1564, 2iagA, 0.7873, 3.61, 0.120, 471, 374, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE
1565, 3r1bD, 0.7870, 3.84, 0.150, 464, 379, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1566, 3b4xA, 0.7869, 2.45, 0.238, 367, 340, CRYSTAL STRUCTURE ANALYSIS OF SULFOLOBUS TOKODAII STRAIN7 CYTOCHROM P450
1567, 4dvqK, 0.7866, 3.63, 0.162, 460, 376, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1568, 4dvqL, 0.7858, 3.49, 0.156, 454, 372, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1569, 1po5A, 0.7853, 3.83, 0.151, 465, 377, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4
1570, 3qi8A, 0.7852, 3.34, 0.133, 424, 360, EVOLVED VARIANT OF CYTOCHROME P450 (BM3 CYP102A1)
1571, 3g5nB, 0.7847, 3.61, 0.168, 451, 368, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1572, 2rcmB, 0.7843, 3.68, 0.119, 465, 369, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A) AT 1.73 A RESOLUTION
1573, 1f4tB, 0.7843, 2.58, 0.259, 367, 340, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS WITH 4- PHENYLIMIDAZOLE BOUND
1574, 1io9B, 0.7840, 2.28, 0.259, 354, 336, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1575, 4zgxI, 0.7838, 3.57, 0.155, 458, 373, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1576, 3g5nD, 0.7838, 3.59, 0.163, 451, 368, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1577, 3dskB, 0.7838, 3.70, 0.119, 465, 369, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 1.55 A RESOLUTION
1578, 3dsjB, 0.7838, 3.73, 0.122, 465, 370, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.60 A RESOLUTION
1579, 3g5nC, 0.7837, 3.74, 0.165, 452, 369, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1580, 3dsiB, 0.7836, 3.73, 0.122, 465, 370, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOT AT 1.60 A RESOLUTION
1581, 3cliB, 0.7834, 3.74, 0.122, 465, 370, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) AT 1.80 A RESOLUTION
1582, 2rclB, 0.7832, 3.74, 0.122, 465, 370, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 2.4 A RESOLUTION
1583, 2rchB, 0.7831, 3.74, 0.122, 465, 370, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.85 A RESOLUTION
1584, 4wpdA, 0.7826, 2.60, 0.256, 367, 340, X-RAY CRYSTAL STRUCTURE OF CYP119 COMPLEXED WITH 4-(4-FLOUROPHENYL)- 1H-IMIDAZOLE
1585, 1f4tA, 0.7824, 2.61, 0.259, 367, 340, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS WITH 4- PHENYLIMIDAZOLE BOUND
1586, 1io7B, 0.7817, 2.61, 0.256, 359, 340, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1587, 4wpdB, 0.7815, 2.51, 0.257, 367, 339, X-RAY CRYSTAL STRUCTURE OF CYP119 COMPLEXED WITH 4-(4-FLOUROPHENYL)- 1H-IMIDAZOLE
1588, 3b98A, 0.7812, 3.80, 0.146, 446, 377, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1)
1589, 1f4uB, 0.7810, 2.45, 0.258, 366, 337, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS
1590, 1f4uA, 0.7810, 2.45, 0.258, 366, 337, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS
1591, 1io8B, 0.7809, 2.54, 0.257, 359, 339, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1592, 3g93A, 0.7802, 3.76, 0.165, 454, 370, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1593, 2rfcC, 0.7799, 2.30, 0.247, 338, 336, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1594, 3b99A, 0.7794, 3.87, 0.143, 445, 377, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1) IN COMPLEX WITH SUBSTRATE ANALOG U51605
1595, 2rfcD, 0.7781, 2.32, 0.247, 338, 336, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1596, 2rfcA, 0.7781, 2.35, 0.241, 338, 336, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1597, 2bz9B, 0.7772, 3.46, 0.175, 432, 365, LIGAND-FREE STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE FROM MYCOBACTERIUM TUBERCULOSIS IN P2(1) SPACE GROUP
1598, 1n97A, 0.7761, 3.09, 0.154, 385, 351, CRYSTAL STUCTURE OF CYP175A1 FROM THERMUS THERMOPHILLUS STRAIN HB27
1599, 4r1zA, 0.7759, 3.13, 0.164, 417, 353, ZEBRA FISH CYTOCHROME P450 17A1 WITH ABIRATERONE
1600, 2rfbA, 0.7754, 2.43, 0.250, 338, 336, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1601, 4r1zB, 0.7727, 3.24, 0.164, 411, 354, ZEBRA FISH CYTOCHROME P450 17A1 WITH ABIRATERONE
1602, 2rfcB, 0.7724, 2.47, 0.244, 338, 336, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1603, 1n97B, 0.7716, 3.23, 0.150, 385, 353, CRYSTAL STUCTURE OF CYP175A1 FROM THERMUS THERMOPHILLUS STRAIN HB27
1604, 1e9xA, 0.7714, 3.94, 0.159, 449, 372, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH 4-PHENYLIMIDAZOLE
1605, 2bz9A, 0.7685, 3.50, 0.169, 429, 362, LIGAND-FREE STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE FROM MYCOBACTERIUM TUBERCULOSIS IN P2(1) SPACE GROUP
1606, 3daxA, 0.7680, 3.94, 0.148, 472, 372, CRYSTAL STRUCTURE OF HUMAN CYP7A1
1607, 3v8dA, 0.7677, 4.08, 0.144, 479, 375, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH 7-KETOCHOLESTEROL
1608, 2w0bA, 0.7674, 3.97, 0.162, 440, 370, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR 3-{[(4- METHYLPHENYL)SULFONYL]AMINO}PROPYL PYRIDIN-4-YLCARBAMATE
1609, 3daxB, 0.7670, 3.93, 0.145, 470, 372, CRYSTAL STRUCTURE OF HUMAN CYP7A1
1610, 1x8vA, 0.7659, 3.62, 0.174, 429, 362, ESTRIOL-BOUND AND LIGAND-FREE STRUCTURES OF STEROL 14ALPHA- DEMETHYLASE (CYP51)
1611, 3g93B, 0.7658, 3.64, 0.172, 442, 360, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1612, 1ea1A, 0.7657, 4.09, 0.158, 447, 373, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH FLUCONAZOLE
1613, 2rfbC, 0.7656, 2.36, 0.254, 333, 331, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1614, 2rfbB, 0.7650, 2.60, 0.246, 335, 333, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1615, 3sn5A, 0.7646, 4.03, 0.142, 468, 374, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH CHOLEST-4-EN-3-ONE
1616, 3v8dB, 0.7633, 4.08, 0.137, 467, 373, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH 7-KETOCHOLESTEROL
1617, 1u13A, 0.7623, 3.79, 0.168, 433, 364, CRYSTAL STRUCTURE ANALYSIS OF THE C37L/C151T/C442A-TRIPLE MUTANT OF CYP51 FROM MYCOBACTERIUM TUBERCULOSIS
1618, 3b98B, 0.7622, 3.61, 0.141, 427, 362, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1)
1619, 1wiyB, 0.7610, 3.19, 0.153, 362, 347, CRYSTAL STRUCTURE ANALYSIS OF A 6-COORDINATED CYTOCHOROME P450 FROM THERMUS THERMOPHILUS HB8
1620, 3sn5B, 0.7607, 3.93, 0.144, 466, 369, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH CHOLEST-4-EN-3-ONE
1621, 3g93D, 0.7607, 3.74, 0.172, 440, 360, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1622, 3g93C, 0.7601, 3.79, 0.172, 442, 361, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1623, 3dbgB, 0.7596, 2.63, 0.193, 379, 336, CRYSTAL STRUCTURE OF CYTOCHROME P450 170A1 (CYP170A1) FROM STREPTOMYCES COELICOLOR
1624, 3dbgA, 0.7596, 2.63, 0.193, 379, 336, CRYSTAL STRUCTURE OF CYTOCHROME P450 170A1 (CYP170A1) FROM STREPTOMYCES COELICOLOR
1625, 1wiyA, 0.7596, 3.22, 0.147, 358, 346, CRYSTAL STRUCTURE ANALYSIS OF A 6-COORDINATED CYTOCHOROME P450 FROM THERMUS THERMOPHILUS HB8
1626, 1h5zA, 0.7569, 3.87, 0.165, 434, 363, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN FERRIC LOW-SPIN STATE
1627, 2bdmA, 0.7552, 4.33, 0.135, 465, 377, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND BIFONAZOLE
1628, 2w09A, 0.7528, 3.70, 0.176, 421, 357, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR CIS-4- METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4- YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE
1629, 2w0aA, 0.7494, 3.85, 0.178, 424, 359, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR N-[(1S)-2-METHYL-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL] CYCLOHEXANECARBOXAMIDE
1630, 3b99B, 0.7472, 3.67, 0.138, 415, 355, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1) IN COMPLEX WITH SUBSTRATE ANALOG U51605
1631, 2ci0A, 0.7461, 3.75, 0.177, 421, 355, HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS
1632, 2cibA, 0.7460, 3.69, 0.178, 419, 354, HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS
1633, 5bv5A, 0.7166, 2.47, 0.247, 315, 312, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1634, 5bv5D, 0.7141, 2.92, 0.242, 327, 318, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1635, 5bv5C, 0.6947, 2.82, 0.254, 311, 307, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1636, 5bv5B, 0.6698, 2.06, 0.245, 288, 286, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1637, 5mnvI, 0.6555, 2.59, 0.316, 286, 285, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1638, 2yjnB, 0.6418, 3.45, 0.209, 337, 297, STRUCTURE OF THE GLYCOSYLTRANSFERASE ERYCIII FROM THE ERYTHROMYCIN BIOSYNTHETIC PATHWAY IN COMPLEX WITH ITS ACTIVATING PARTNER ERYCII
